{"FP": [{"generated": ["Case report"], "gold": [], "text": "Progressive mobilization of the patient was obtained as well as a complete normalization of the laboratory findings."}, {"generated": ["Case report"], "gold": [], "text": "We describe here the unexpected onset of heavy toxicity including rhabdomyolysis after the fourth course of trabectedin in a patient with retroperitoneal liposarcoma who at the same time was taking an alternative herbal medicine suspected of triggering this adverse event."}, {"generated": ["Case report"], "gold": [], "text": "In spite of chemotherapy, the lesion progressed rapidly reaching 16 \u00d7 10 cm and extending into the pre-aortic seat of the retro-peritoneum space."}, {"generated": ["Case report"], "gold": [], "text": "Due to the absence of co-morbidity, the patient had not received any other drugs during treatment with trabectedin."}, {"generated": ["Case report"], "gold": [], "text": "This case report highlights the complexity associated with medicinal cannabis and the health risks associated with its use."}, {"generated": ["Citation"], "gold": [], "text": "Neuronal death in this region results in low dopamine concentrations; therefore, treatment strategies for PD often involve initiating medications (e.g., carbidopa-levodopa, ropinirole, entacapone) that result in increased concentrations of dopamine to improve movement control [8]."}, {"generated": ["Case report"], "gold": [], "text": "The case described herein demonstrates the importance of considering the pharmacokinetic and pharmacodynamic effects of cannabis and an individual\u2019s pharmacogenomic (PGx) data when evaluating a patient\u2019s medication regimen for therapeutic response and/or adverse drug events."}, {"generated": ["Case report"], "gold": [], "text": "The clinical pharmacist recommended dose increases of carbidopa-levodopa to help control his tremors still present early in the morning (Figure 1)."}, {"generated": ["Case report"], "gold": [], "text": "However, his PCP determined that additional medication for pain control was warranted."}, {"generated": ["Patient's PGx results reporting"], "gold": [], "text": "Interestingly, the patient\u2019s PGx results (Table 1) reported a genotype for COMT Met/Met, therefore higher levels of dopamine in his synapses would be expected."}, {"generated": [1], "gold": [], "text": "Additionally, a previous study evaluated patients with PD and their subsequent reactions to cannabis use, reporting that one out of five patients experienced hallucinations [12]."}, {"generated": ["Clinical case report"], "gold": [], "text": "Given this patient\u2019s genetic results, guidelines, and current pain status, the clinical pharmacist suggested morphine as an alternative, as it does not utilize CYP2D6 for metabolism [34]."}, {"generated": ["Description of trend in medicine over the past two decades"], "gold": [], "text": "During the past two decades, the world has witnessed an increased rate of conventional medicines integrated with CAM for treatment."}, {"generated": ["Survey"], "gold": [], "text": "In China, 93.4% of cancer patients reported having used CAM in 2009-2010 [4]."}, {"generated": ["survey or report"], "gold": [], "text": "In South Korean population reported a range from 29% to 83% [5]."}, {"generated": ["Description of study not provided"], "gold": [], "text": "An important fact is that most of these affected drugs have very narrow therapeutic indices."}, {"generated": ["reports on studies evaluating HDIs (hydroxylic compounds)"], "gold": [], "text": "To date an increasing number of studies in evaluating HDIs have been reported [11]."}, {"generated": ["Observational Study or Association Study"], "gold": [], "text": "Therefore, rs1142345 was associated with the clinical effect of traditional hypoglycemic herbs."}, {"generated": ["Scientific article"], "gold": [], "text": "The cytochrome P450 (CYP450) family of enzymes especially plays an important role in the biotransformation of about 70% of xenobiotics and other endogenous substances [14]."}, {"generated": ["research study"], "gold": [], "text": "This study concentrated on investigating the effects of potential interaction between extracts from Newbouldia laevis and Cassia abbreviata on CYP1A2, CYP2C9, and CYP2C19 activities."}, {"generated": ["researchers are adopting the guidelines and opinions proposed for DDI studies"], "gold": ["DDI studies"], "text": "With the tremendous surge in the acceptance of and public interest in herbal medicinal remedies, researchers are adopting the guidelines and opinions proposed for DDI studies to study HDI."}, {"generated": ["Discussion"], "gold": [], "text": "The TDI effects of these herbals is felt when patients chronically use them because sufficient intermediary metabolites may be generated and this can be deleterious to consumers concomitantly taking conventional medications, as stated earlier."}, {"generated": ["Laboratory experiment"], "gold": [], "text": "Extraction was performed using water to mimic the indigenous mode of extraction."}, {"generated": ["In vitro"], "gold": [], "text": "[44]."}, {"generated": ["Research article"], "gold": [], "text": "Currently, there is no specific pharmacological tool to predict HDI since almost all in vitro-in vivo-extrapolation (IVIVE) Drug-Drug Interaction (DDI) models deal with one inhibitor-drug and one victim-drug."}, {"generated": ["research article or review article"], "gold": [], "text": "Further, unique substrates that interact with Oat1, but not with Oat3 (and vice-versa) have been identified [7]."}, {"generated": ["Study published in 2001"], "gold": [], "text": "Furthermore, 31% of diabetic patients have been reported to take alternative medicines, most in conjunction with conventional medicines (Ryan et al., 2001)."}, {"generated": ["Study by Elliot and colleagues"], "gold": [], "text": "Elliot et al."}, {"generated": ["Laboratory experiment"], "gold": [], "text": "Detection of the CYP2C9*2 and CYP2C9*3 alleles were carried out using a polymerase chain reaction based restriction fragment length polymorphism (polymerase chain reaction-RFLP) analysis."}, {"generated": ["Research article or study"], "gold": [], "text": "Park et al."}, {"generated": ["Diagnostic study"], "gold": [], "text": "Serological titers for acute cytomegalovirus (CMV) and Epstein Barr virus (EBV) were negative."}, {"generated": ["Laboratory test result"], "gold": [], "text": "Antinuclear antibody (ANA) was 1 : 40 and smooth muscle antibody was modestly elevated at 1 : 80."}, {"generated": ["Pathology study"], "gold": [], "text": "At this time, the liver histology demonstrated chronic hepatitis with fibroinflammatory expansion of portal tracts by moderate plasma cell rich interface hepatitis, rare periportal hepatocyte apoptosis, and mild cholangiolar proliferation (Figures 1(a) and 1(b))."}, {"generated": ["Case report"], "gold": [], "text": "The clinicopathological features of Case 1 are illustrated in Tables 1, 2, and 3."}, {"generated": ["Case report"], "gold": [], "text": "Although she was initially asymptomatic, she developed right upper quadrant abdominal pain, fatigue, and lower extremity edema by the time of her presentation."}, {"generated": ["Recommendation"], "gold": [], "text": "The American College of Obstetrics and Gynecology included black cohosh as a possible remedy for the vasomotor symptoms of menopause [15]."}, {"generated": ["Case report"], "gold": [], "text": "This case culminated in liver failure despite discontinuation of the herbal supplement [4]."}, {"generated": ["Citation"], "gold": [], "text": "The immune mechanism is precipitated by a drug or a metabolite acting as a hapten covalently binding to host cellular protein, converting into an immunogen [24] and thereby eliciting an autoimmune response."}, {"generated": ["Scale or Tool"], "gold": [], "text": "Naranjo [8] Causality Scale for Adverse Drug Reactions."}, {"generated": ["Review article"], "gold": [], "text": "Similarities and differences among current case studies and published cases of black cohosh hepatotoxicity."}, {"generated": ["Citation"], "gold": [], "text": "Levofloxacin (LVFX) is used to treat numerous bacterial infections belonging to the third-generation fluoroquinolone antibiotic family [8]."}, {"generated": ["Description of practice for patients with urinary system infection"], "gold": [], "text": "For patients with urinary system infection, Relinqing\u00ae granule from Polygonum capitatum is usually combined with LVFX."}, {"generated": ["No specific type mentioned"], "gold": [], "text": "Group one was administered 42\u2009mg\u00b7kg Data are presented as mean\u2009\u00b1\u2009standard deviation (SD)."}, {"generated": ["research finding or validation of method"], "gold": [], "text": "Based on our findings, the developed method is acceptable and accurate for analyzing LVFX in complex matrices."}, {"generated": ["Unspecified"], "gold": [], "text": "The diluted samples were analyzed using a calibration curve to derive their integrities, which were within the acceptable limit of \u00b115%."}, {"generated": ["None"], "gold": [], "text": "Polygonum capitatum may inhibit the entrance of LVFX into blood, thereby directly affecting its distribution rate in the tissue."}, {"generated": ["pharmacokinetic studies"], "gold": [], "text": "At present, our current studies at the pharmacokinetic level may not be able to explain this problem strongly."}, {"generated": ["No study mentioned in the text"], "gold": [], "text": "People with diabetes receiving this combination should be closely monitored to evaluate possible signs of reduced efficacy."}, {"generated": ["Experimental"], "gold": [], "text": "*P < 0.05, **P < 0.01, and ***P < 0.001, determined by One way ANOVA, followed by Dunnett\u2019s multiple comparison tests."}, {"generated": ["Citation"], "gold": [], "text": "Flavonoids, common in the diet, are responsible for the modulation of the clinically relevant CYP2C8, CYP2C9, and CYP3A4 enzymes [31]."}, {"generated": ["Screening study"], "gold": [], "text": "Qualitative screening of extracts and compounds was used to identify potential inhibitory effects on CYP2C8, CYP2C9 and CYP3A4."}, {"generated": ["clinical trial or study"], "gold": [], "text": "Echinacea was well tolerated, and all participants completed the study."}, {"generated": ["In vitro"], "gold": [], "text": "2)."}, {"generated": ["Study"], "gold": [], "text": "This result was statistically not significant."}, {"generated": ["Clinical trial or study"], "gold": [], "text": "The commercially available E. purpurea extract did not significantly alter the pharmacokinetics of docetaxel."}, {"generated": ["Clinical trial"], "gold": [], "text": "The secondary objective was to assess the effect of E. purpurea supplementation on safety parameters, such as grade 3 and 4 toxicities induced by docetaxel [according to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE, version 3.0)]."}, {"generated": ["Not specified"], "gold": [], "text": "Subsequently, plasma was separated and stored at \u221220\u00b0C until analysis."}, {"generated": ["No study described"], "gold": [], "text": "Our commercial product was only labelled to contain 95% aerial parts and 5% roots of E. purpurea, and no information was provided about the total amount of extract used."}, {"generated": ["Our group has shown"], "gold": [], "text": "In LS180 cells, our group has shown significant induction of CYP3A4 by isolated alkylamides and E. purpurea extracts using a gene reporter assay, which is a reliable method to assess the CYP3A4 induction potential of compounds [23]."}, {"generated": ["Clinical trial"], "gold": [], "text": "Considering the risk of tumour progression, randomization was not in the interest of patients with advanced cancer."}, {"generated": ["Description of study not provided"], "gold": [], "text": "Thus, the risk of CYP3A4-mediated interactions may be product dependent."}, {"generated": ["Laboratory experiment"], "gold": [], "text": "DNA was isolated from the 200 \u00b5L of whole blood samples using a QIAamp DNA Blood Mini Kit (Qiagen, Germantown, MD, USA)."}, {"generated": ["Clinical trial"], "gold": [], "text": "Sixteen subjects reported 27 adverse events."}, {"generated": ["Clinical trial"], "gold": [], "text": "All the adverse events were mild in intensity and resolved without any treatment."}, {"generated": ["clinical trial or investigation"], "gold": [], "text": "Surprisingly, the coadministration of GTC reduced the systemic exposure of digoxin in this study."}, {"generated": ["Study"], "gold": [], "text": "Relationship between the catechin AUC Abbreviations: AUC Subject baseline characteristics at the start of the study Note: Data are presented as mean \u00b1 SD for continuous variables and as ratios for categorical variables."}, {"generated": ["Clinical trial"], "gold": [], "text": "Biliary excretion, but not urinary excretion, of methotrexate decreased in the RGE repeated administration group, compared to that in the control group."}, {"generated": ["Animal study"], "gold": [], "text": "Next, we investigated the effects of RGE on the biliary excretion of Mrp2 substrate drug in rats."}, {"generated": ["Discussion of potential treatment for rheumatoid arthritis"], "gold": [], "text": "Therefore, the use of MTX and red ginseng alone or in combination is highly plausible for treatment of rheumatoid arthritis."}, {"generated": ["an in vivo study on rats"], "gold": [], "text": "Therefore, in conclusion, this study showed that the herb\u2013drug interactions between red ginseng and MTX occurred via Mrp2 regulation changes in rats, but clinical significance thereof should be determined with follow-up studies."}, {"generated": ["Not applicable"], "gold": [], "text": "The concentration of total RNA was determined by Nano Vue Plus (GE healthcare Korea, Seoul, Korea)."}, {"generated": ["Pharmacokinetic"], "gold": [], "text": "Pharmacokinetic studies started 2 h after the last RGE treatment."}, {"generated": ["Conceptualization"], "gold": [], "text": "Conceptualization, M.-K.C."}, {"generated": ["Content analysis"], "gold": [], "text": "Contents of ginsenosides in RGE."}, {"generated": ["Publication"], "gold": [], "text": "2016; Bautista et\u00a0al."}, {"generated": ["Study published in 2014"], "gold": [], "text": "2014; Dybro et\u00a0al."}, {"generated": ["Research article"], "gold": [], "text": "However, it is unknown whether there is an interaction between AC and DST."}, {"generated": ["N/A"], "gold": [], "text": "; 3.5\u2009\u03bcm) at room temperature."}, {"generated": ["In vitro"], "gold": [], "text": "The maximum plasma concentration (C Rat liver microsomes were used to determine the metabolic rate of AC."}, {"generated": ["Experimental"], "gold": [], "text": "The half-life (t Experimental values are expressed as mean\u2009\u00b1\u2009SD."}, {"generated": ["Laboratory experiment"], "gold": [], "text": "The highest recovery was obtained using acetonitrile as a protein precipitant."}, {"generated": ["In vivo study"], "gold": [], "text": "In the present study, the selectivity was examined using independent plasma samples from six different rats."}, {"generated": ["In vitro experiment"], "gold": [], "text": "Linearity for AC was obtained over the concentration range of 1\u2013500\u2009ng/mL."}, {"generated": ["research data"], "gold": [], "text": "These data indicated that the accuracy and precision of the method were satisfactory."}, {"generated": ["No specific study mentioned"], "gold": [], "text": "Its effective plasma drug concentration is close to the toxic concentration, and large individual differences in the effects of the drug have been observed."}, {"generated": ["Review of existing studies"], "gold": [], "text": "The results of existing studies are controversial and further in-depth studies are required."}, {"generated": ["Literature analysis"], "gold": [], "text": "Based on our analysis of the literature, the mechanism of interaction between TCM formulations and digoxin is as follows: A."}, {"generated": ["Animal experiment"], "gold": [], "text": "Experiments in mice have shown that the AUC of digoxin is increased by gavage and intravenous injection."}, {"generated": ["Research Study"], "gold": [], "text": "Li Xin et al."}, {"generated": ["Publication"], "gold": [], "text": "When the bias of medicine is greater than that of food, it will inevitably affect the balance of qi, blood, yin and yang of the human body (Jia et al., 2021)."}, {"generated": ["Clinical experience"], "gold": [], "text": "Although a lot of experience has been accumulated in the clinical application of digoxin over the years, limited research has been conducted on its possible interactions with TCM formulations."}, {"generated": ["Description of TCM formulations"], "gold": [], "text": "The composition of TCM formulations is complex."}, {"generated": ["Discussion about the interactions between TCM formulations and digoxin"], "gold": [], "text": "Therefore, the interactions between TCM formulations and digoxin are difficult to elucidate, and they are easily ignored by physicians."}, {"generated": ["Publication"], "gold": [], "text": "Hepatocytes cultured in this format are responsive to nuclear receptor agonists and maintain important transporter function necessary for proper drug disposition (Yang et al., 2016)."}, {"generated": ["Study description not provided"], "gold": [], "text": "C. asiatica Plant Material and Preparation of CAW-R61J."}, {"generated": ["In vitro study"], "gold": [], "text": "Potential TDI of P450 enzyme activity by CAW-R61J was determined using the shift in IC50 values between 30-minute preincubations in the presence and absence of NADPH."}, {"generated": ["In vitro"], "gold": [], "text": "Unless otherwise specified, all results were expressed as the means \u00b1 S.D."}, {"generated": ["In vitro study"], "gold": [], "text": "2 above (substituting logEC50 for logIC50)."}, {"generated": ["In vitro"], "gold": [], "text": "Mean\tS.D."}, {"generated": ["In vitro"], "gold": [], "text": "Mean\tS.D."}, {"generated": ["In vitro and in vivo"], "gold": [], "text": "***P < 0.0001."}, {"generated": ["In vitro"], "gold": [], "text": "; data not shown)."}, {"generated": ["In vitro"], "gold": [], "text": "of triplicate determinations."}, {"generated": ["In vitro study"], "gold": [], "text": "Ultimately, the clinical relevance of the weak P450 inhibition seen in this study will depend on the IC50 values of the as yet unknown inhibitory CAW-R61J compounds and their in vivo concentration achieved in humans."}, {"generated": ["Clinical trial"], "gold": [], "text": "Therefore, the tolerability and safety of combination drugs were evaluated in the context of their DDI potential."}, {"generated": ["Three concentrations of quality control samples were prepared in the range of the standard calibration curves"], "gold": [], "text": "Three concentrations of quality control (QC) samples were prepared at low, medium, and high concentrations in the range of the standard calibration curves."}, {"generated": ["Post-preparative stability evaluation"], "gold": [], "text": "Post-preparative stability was evaluated by comparing the extracted QC samples maintained in the autosampler at 6 \u00b0C for 24 h (compared with the untreated QC samples)."}, {"generated": ["Laboratory experiment"], "gold": [], "text": "For amlodipine analysis, 50 \u03bcL aliquots were mixed with 150 \u03bcL acetonitrile containing 1 ng/mL berberine (IS)."}, {"generated": ["Previously published reports"], "gold": [], "text": "The ionization mode and mass transition from Q1 to Q3 were selected based on the product ion scan results of authentic standards and previously published reports (Figure 1)."}, {"generated": ["Bioanalytical method validation"], "gold": [], "text": "Owing to slight variations in the analytical process (e.g., changes in recovery during preparation of a biological sample and variability in the performance of the analytical instrument), there may be cases where the response of a QC sample is higher than that of a standard curve sample, but the inter- and intra-day accuracy in Table 2 were within the acceptance criteria for accuracy (i.e., 85~115%) according to the Guideline of Bioanalytical method validation from FDA, EMA, and ICH [37]."}, {"generated": ["research article"], "gold": [], "text": "These results suggest that fimasartan is an attractive candidate for the treatment of hypertension and suggest the increasing use of fimasartan monotherapy and combination therapy."}, {"generated": ["In vitro study"], "gold": [], "text": "and M.P."}, {"generated": ["Discussion of challenges associated with long-term administration of HAART (Highly Active Antiretroviral Therapy)"], "gold": [], "text": "However, there are several challenges associated with the chronic nature of HAART administration."}, {"generated": ["Research article"], "gold": [], "text": "Although effective in the treatment of some diseases, the mechanisms of action for most herbal medicines remain largely unknown."}, {"generated": ["Research article"], "gold": [], "text": "Genetic polymorphism in CYP2B6 have been implicated in variations in the activity of the enzyme in metabolizing xenobiotics [26]."}, {"generated": ["Research article"], "gold": [], "text": "Since the intestinal absorption and plasma concentrations of each test compound are not known, and with the knowledge that herbal extracts have different bioavailability [28], the estimated bioavailable concentration was calculated using the % yield to give the soluble extract available in the GI tract."}, {"generated": ["Description of study process"], "gold": [], "text": "The advantage of phytochemical profiling is that similar drug interacting constituents could be identified in other related herbs that are used for therapeutic purposes and that necessary mechanistic studies are performed on them."}, {"generated": ["Not specified"], "gold": [], "text": "The material was allowed to extract for 72 h at room temperature during which supernatant was decanted every 24 h and the solid residue reconstituted in the same volume of purified water for the extraction process to be repeated."}, {"generated": ["No study described"], "gold": [], "text": "Denis Chopera, Kevin Dzobo, Ambroise Wonkam, Dee Blackhurst and Michelle Skelton commented."}, {"generated": ["Research article"], "gold": [], "text": "All authors reviewed the final manuscript."}, {"generated": ["Clinical trial"], "gold": [], "text": "Each participant received three treatments with a 7 \u00b1 1-day washout period in-between."}, {"generated": ["experimental"], "gold": [], "text": "Therefore, we applied this dose of GGT in our study."}, {"generated": ["Recommendation studies"], "gold": [], "text": "To mimic the recommended dose based on the status of patients, AAP dose is suggested from 1000 mg to the maximum dose of 1000 mg \u00d7 4 times (8 tablets) per day for treatment of the common cold [22,23]."}, {"generated": ["Clinical trial or study"], "gold": [], "text": "AAP at 1000 once a day or 1000 mg \u00d7 4 times a day was administered in the presence or absence of GGT (7680 mg) daily."}, {"generated": ["In vitro"], "gold": [], "text": "and Y.C.P."}, {"generated": ["Pharmacokinetic study"], "gold": [], "text": "Non-compartmental analysis (NCA) result of pharmacokinetic (PK) parameters of AAP."}, {"generated": ["Clinical trial"], "gold": [], "text": "Adherence to these restrictions was further emphasized five days before each probe drug administration."}, {"generated": ["Experimental"], "gold": [], "text": "Peaks were assigned by a comparison of retention times and ultraviolet absorption spectra."}, {"generated": ["Clinical trial or investigation"], "gold": [], "text": "[45] Go to: RESULTS General Experimental Observations  All subjects completed the study and no serious adverse events occurred during the course of the investigation."}, {"generated": ["single-time point phenotypic ratio approach"], "gold": [], "text": "[17] The single-time point phenotypic ratio approach confirmed what other investigators observed with St. John\u2019s wort when more conventional \u201carea-under-the-curve\u201d methods were utilized to determine midazolam clearance."}, {"generated": ["earlier study"], "gold": [], "text": "This finding also corroborates the results of an earlier study in young individuals."}, {"generated": ["Study finding a potential interaction"], "gold": [], "text": "[54] Thus, a potential interaction may exist between these agents and St. John\u2019s wort."}, {"generated": ["Observational study"], "gold": [], "text": "[42] The difference in extent of inhibition between the two age groups hints at either an age-related diminution in CYP2E1 responsivity or a dissimilarity in allyl sulfide content between the garlic supplements."}, {"generated": ["No specific study mentioned"], "gold": [], "text": "[11,12] Such an interaction is particularly relevant to elderly patients on anticoagulant therapy."}, {"generated": ["In vitro interaction study"], "gold": [], "text": "This interaction appears attributable to the inhibition of platelet activating factor by various ginkgolides."}, {"generated": ["In vitro investigation"], "gold": [], "text": "Like G. biloba, Panax ginseng appears to have little effect on the activities of the specific CYP isoforms investigated in this study."}, {"generated": ["Discussion of potential interactions between botanical supplements and conventional medications"], "gold": [], "text": "Therefore, botanical supplements, when taken concomitantly with conventional medications, can give rise to serious herb-drug interactions."}, {"generated": ["Laboratory experiment"], "gold": [], "text": "Blood samples were collected and analyzed for plasma quinine and its metabolite, (3-hydroxyquinine) using a validated HPLC method."}, {"generated": ["research study"], "gold": [], "text": "Pregnancy, breastfeeding, histories of hypersensitivity to quinine or similar agents, or adverse side effects from taking G. kola seeds were also used as exclusion criteria for the study."}, {"generated": ["Limit of quantitation study"], "gold": [], "text": "The limit of quantitation was 0.37\u00b5g/ml and 0.5\u00b5g/ml for quinine and for 3-hydroxyquinine respectively."}, {"generated": ["Findings from a study"], "gold": [], "text": "The AUC0\u2013\u221e of quinine was slightly reduced by about 9 %."}, {"generated": ["Clinical trial with 3 participants"], "gold": [], "text": "Precisely, only 3 participants complained of very light dizziness."}, {"generated": ["Clinical trial"], "gold": [], "text": "In Stage 2 77 additional participants were randomized to either 1,200 mg S. frutescens or placebo."}, {"generated": ["clinical trial or study"], "gold": [], "text": "With respect to the MOS-HIV, failure differences were found between placebo and 1200 mg, favouring the 1200mg group."}, {"generated": ["Clinical trial or study"], "gold": ["both arms"], "text": "On serial electrocardiograms the PR interval, QRS duration and corrected QT interval (QTc) were similar in both arms (S2 Table)."}, {"generated": ["In vitro"], "gold": [], "text": "(PDF) Click here for additional data file."}, {"generated": ["Author(s)"], "gold": [], "text": "Thabethe, D.A."}, {"generated": ["Descriptive"], "gold": [], "text": "Data were reported as prevalence (percent) of the occurrence."}, {"generated": ["Multiple studies"], "gold": [], "text": "However, a large number of these therapies have been shown that they are not safe and can be harmful due to their interactions with other drugs which are used contemporaneously."}, {"generated": ["Description of study population"], "gold": [], "text": "Regarding CAM nonusers, the majority were in the age group of 20\u201360 years with the male/female ratio of 73/27 percent."}, {"generated": ["Observational study"], "gold": [], "text": "The majority of the patients identified as herbal users were in the age range of 50\u201370 years, and herbal usage prevalence was high among this age range."}, {"generated": ["study reported"], "gold": [], "text": "'s study,[25] which reported that the trend was more prevalent among middle-aged (50\u201364) patients compared to other age groups."}, {"generated": ["study performed by"], "gold": [], "text": "[27] In the study performed by Roozbeh et al."}, {"generated": ["Case report"], "gold": [], "text": "The patient had a Karnofsky performance status scale of 90% after resection without neurological deficiencies and was referred to our department for further treatment with radiotherapy and temozolomide (TEM)."}, {"generated": ["Case report"], "gold": [], "text": "Unfortunately, a [18 F]-fluorethylenthyrosin positron emission tomography positive residual tumor was detected 2 months after the end of radiotherapy."}, {"generated": ["Discussion"], "gold": [], "text": "Therefore, we think that a comprehensive management of our patients should also include education about the risk of interactions with herbal formulas."}, {"generated": ["Observational study"], "gold": [], "text": "International normalized ratio  International normalized ratio was measured at each blood sampling time before and after warfarin dosing using a BFT II analyser."}, {"generated": ["In vitro study"], "gold": [], "text": "Percentage factor activity for each sample was obtained from a standard curve constructed using different dilutions of standard human plasma of known factor activity and clotting time."}, {"generated": ["Experimental"], "gold": [], "text": "However, this did not reach statistical significance (data not shown)."}, {"generated": ["Pharmacokinetic-pharmacodynamic modelling study"], "gold": [], "text": "Pharmacokinetic\u2013pharmacodynamic modelling  The population PKPD parameter estimates for warfarin are presented in the Table 3."}, {"generated": ["investigation"], "gold": [], "text": "(2007) also investigated the effect of pretreatment with cranberry juice for 5 days on warfarin pharmacokinetics and found no clinically significant change in the AUC of S-warfarin."}, {"generated": ["concluded"], "gold": [], "text": "(2007) concluded that there were no pharmacodynamic interactions between warfarin and cranberry juice, but they employed a low dose of warfarin (10\u2009mg), which made this end point difficult to assess."}, {"generated": ["Descriptive"], "gold": [], "text": "However, they state that warnings that valerian (Valeriana officinalis) may stimulate CYP 3A4."}, {"generated": ["Literature search"], "gold": [], "text": "A search with the search terms (valerian or valeriana) was conducted in the databases MEDLINE and TOXLIT, via DIMDI (Cologne, Germany)."}, {"generated": ["Assessment studies"], "gold": [], "text": "Studies were assessed for completeness and validity of data on material and methods, on the potential clinical relevance of the results and on potential bias in the presentation of results and conclusions."}, {"generated": ["In vitro"], "gold": [], "text": "[36]."}, {"generated": ["Experimental"], "gold": [], "text": "The results were not presented in detail but indicated that the two drugs act independently from each other."}, {"generated": ["two case reports"], "gold": [], "text": "A possible pharmacodynamic interaction of valerian preparations with other drugs is supported only by two case reports."}, {"generated": ["Case report"], "gold": [], "text": "Given that none of these herbal medicines has been proven to have MAO-inhibitory properties, while induction of delirium, and a positive drug screening on opioids was reported, the assumption of an involvement of the valerian preparation does not seem to be plausible."}, {"generated": ["Discussion"], "gold": [], "text": "A good understanding of the mechanisms of drug-drug interactions is essential for assessing and minimizing clinical risks."}, {"generated": ["Research article"], "gold": [], "text": "Especially the open questions of in vivo bioavailability and of the metabolism of extract components relevant for in vitro effects often prevent reliable extrapolations from in vitro to in vivo data."}, {"generated": ["No clinical observations mentioned"], "gold": [], "text": "At present therefore a relevant risk of pharmacodynamic interactions is not proven by valid clinical observations."}, {"generated": ["monograph of the HMPC [18]", "fact sheet of the Office of Dietary Supplements at the NIH [32]"], "gold": [], "text": "That therapeutic safety regarding interactions is high in valerian and is mentioned in the respective monograph of the HMPC [18] and also in a fact sheet of the Office of Dietary Supplements at the NIH [32]."}, {"generated": ["monograph of the HMPC [18]", "fact sheet of the Office of Dietary Supplements at the NIH [32]"], "gold": [], "text": "That therapeutic safety regarding interactions is high in valerian and is mentioned in the respective monograph of the HMPC [18] and also in a fact sheet of the Office of Dietary Supplements at the NIH [32]."}, {"generated": ["Description of a database"], "gold": [], "text": "In a data base for interactions of medicinal drugs (MedIQ), the rating \u201cweak interaction\u201d is given for CYP-isoenzymes, P-gp, and UGT, based on in vitro data."}, {"generated": ["Summary of a scientific article"], "gold": [], "text": "In summary, it can be concluded that warnings regarding a specific risk of interactions of valerian are without any recent evidence."}, {"generated": ["Research article"], "gold": [], "text": "The authors declare that there is no conflict of interests regarding the publication of this paper."}, {"generated": ["Clinical trial"], "gold": [], "text": "Subjects also received rifampin (600 mg) and clarithromycin (1000 mg) for 7 days as positive controls for CYP3A induction and inhibition, respectively."}, {"generated": ["Case report"], "gold": [], "text": "After venlafaxine discontinuation, there was rapid improvement, with regression of the radiological abnormalities and normalization of the LVEF."}, {"generated": ["Case report"], "gold": [], "text": "This was an important case of drug-induced cardiopulmonary toxicity."}, {"generated": ["Description of a phenomenon"], "gold": [], "text": "Although DIP can occur from hours to months after the beginning of treatment, Another typical feature of DIP is its reversibility after drug discontinuation."}, {"generated": ["Case report"], "gold": [], "text": "The present case details the occurrence of cardiopulmonary toxicity, which was probably associated with venlafaxine."}, {"generated": ["Ampla investigation including LBA, imaging studies, autoimmune diseases detection, right heart catheterization and myocardial biopsy."], "gold": [], "text": "Uma investiga\u00e7\u00e3o ampla foi realizada, incluindo LBA, estudos de imagem, detec\u00e7\u00e3o de doen\u00e7as autoimunes, cateterismo card\u00edaco direito e bi\u00f3psia mioc\u00e1rdica."}, {"generated": ["Observational study"], "gold": [], "text": "A administra\u00e7\u00e3o circunstancial de inibidores da isoenzima CYP2D6 e a presen\u00e7a de um fen\u00f3tipo de metaboliza\u00e7\u00e3o lenta de CYP2D6 podem ter resultado na acumula\u00e7\u00e3o t\u00f3xica da venlafaxina e na manifesta\u00e7\u00e3o cl\u00ednica subsequente."}, {"generated": ["No study described in the given text."], "gold": [], "text": "Os par\u00e2metros renais e hep\u00e1ticos, as prote\u00ednas do complemento e o sedimento urin\u00e1rio estavam todos normais."}, {"generated": ["No specific study mentioned"], "gold": [], "text": "A maioria dos medicamentos card\u00edacos foi, portanto, descontinuada."}, {"generated": ["Case report"], "gold": [], "text": "O caso ocorreu em uma paciente previamente h\u00edgida de 35 anos de idade que foi submetida a investiga\u00e7\u00e3o exaustiva ap\u00f3s a exclus\u00e3o de outras poss\u00edveis causas."}, {"generated": ["Clinical trial"], "gold": [], "text": "This study aims to confirm the safety of red ginseng and herb extract complex (RHC), which are used to relieve menopausal symptoms."}, {"generated": ["Investigation of adverse reactions"], "gold": [], "text": "During the investigation of adverse reactions, the date of onset and disappearance, the degree and result of the adverse reaction, the measures are taken in relation to the test substance and the causal relationship with the test substance, the name of the drug other than the test substance, and treatment of adverse reactions were included."}, {"generated": ["Observational study"], "gold": [], "text": "The examination of demographic information and characteristics before consumption showed no statistically significant difference between the intake groups."}, {"generated": ["clinical trial"], "gold": [], "text": "It is noteworthy that no severe adverse reactions were observed in this study."}, {"generated": ["Research article"], "gold": [], "text": "However, further research is needed on the safety of RHC intake for a long period in large-scale menopausal subjects."}, {"generated": ["Theory or Analysis"], "gold": [], "text": "When the intersection is in the second quadrant and vertical axis for Dixon and Lineweaver-Burk plots respectively, the inhibition type is competitive."}, {"generated": ["Experimental"], "gold": [], "text": "The second plot (Figure 3C) using slope (obtained from Lineweaver-Burk plot) vs. celastrol concentration showed that the inhibition kinetic parameter (Ki) was 0.49 \u03bcM."}, {"generated": ["Research article"], "gold": [], "text": "For example, 120-fold variability of UGT1A6 expression in human liver might result in 13-fold variablity in serotonin glucuronidation [24]."}, {"generated": ["Research article"], "gold": [], "text": "Additionally, it can metabolize many drugs including clofibric acid and valproic acid [25]."}, {"generated": ["study performed by Du et al."], "gold": [], "text": "The previous study performed by Du et al."}, {"generated": ["Inhibition study"], "gold": [], "text": "Inhibition kinetic analysis of celastrol (Cela) towards UGT2B7-catalyzed 4-MU glucuronidation."}, {"generated": ["animal study"], "gold": [], "text": "In case of ginseng interactions, it was reported that no herb\u2013drug interaction between single oral dose of Korean red ginseng extract (RGE) (0.5\u20132.0 g/kg) and the probe substrates for five cytochrome P450 (CYP) enzymes (i.e., CYP1A2, 2C9, 2C19, 2D6, 3A) in mouse [12]."}, {"generated": ["research study"], "gold": [], "text": "The results suggest that valsartan could be used as a model drug for investigating OATP (in human) or Oatp (in rats)-mediated herb\u2013drug interaction between valsartan and RGE or ginsenosides."}, {"generated": ["clinical trial or study"], "gold": [], "text": "The results revealed that the repeated administration of RGE and high dose of Rc did not significantly induce herb\u2013drug interactions involving valsartan (Figure 5 and Figure 8)."}, {"generated": ["In vivo study"], "gold": [], "text": "AUC: area under the plasma concentration-time curve from 0 to 48 h C Pharmacokinetic parameters of valsartan and Rc following intravenous injection of valsartan at a dose of 1 mg/kg in rats."}, {"generated": ["Clinical trial"], "gold": [], "text": "For each visit, a deviation of\u00a0\u00b11\u00a0day was permitted."}, {"generated": ["Clinical trial"], "gold": [], "text": "In order to compensate for study participants who did not complete both treatment phases, a total of 24 subjects were to be randomised."}, {"generated": ["Citation"], "gold": [], "text": "Therefore, use of an herbal agent with antioxidant and polyphenolic properties without significant side effects helps to treat PCOS as a disease of antioxidant deficiency [13]."}, {"generated": ["Clinical trial"], "gold": [], "text": "Furthermore, it decreases insulin and blood glucose markedly [17]."}, {"generated": ["Research article"], "gold": [], "text": "Moreover, hesperidin in C. sinensis increases the levels of antioxidants including SOD and CAT, and decreases the MDA level [19]."}, {"generated": ["Reference"], "gold": [], "text": "A 1,1\u2032,3,3\u2032-tetramethoxypropane was used to construct the calibration curve as the standard [32] (reference value: 0.54\u20131.32 pg/mL)."}, {"generated": ["research study or investigation"], "gold": [], "text": "Descriptive statistics, including the frequency and percentage, and measures of central tendency and dispersion, including the mean and standard deviation (SD), were also used to describe the study variable."}, {"generated": ["Citation"], "gold": [], "text": "In fact, polyphenols determine the antioxidant activity, and this positive relationship renders a trend in many medicinal plants [36]."}, {"generated": ["Experimental"], "gold": [], "text": "particularly illustrated an increase in the SOD, CAT, and GPx levels, while the MDA level more significantly decreased compared to other groups using only one herb [17]."}, {"generated": ["research article"], "gold": [], "text": "demonstrated that ginger could decrease the FBS level by the mechanism of serotonin receptors which activate pancreatic \u03b2 cells to release insulin [56]."}, {"generated": ["research article"], "gold": [], "text": "showed that phenolic phytochemicals of spearmint possessed hypoglycemic, and antioxidant attributes [57]."}, {"generated": ["Observational study or analysis of existing data"], "gold": [], "text": "Polymethoxylated flavones (PMFs) of C. sinensis have hypolipidemic effects, resulting in a significant reduction of insulin tolerance and glucose levels [61]."}, {"generated": ["research"], "gold": [], "text": "All of this research is consistent with our study."}, {"generated": ["N/A"], "gold": [], "text": "Polycystic ovary syndrome (PCOS) patients\u2019 flow diagram."}, {"generated": ["Research article"], "gold": [], "text": "Volatile compounds identified in the essential oil of herbal mixture."}, {"generated": ["Conference presentation"], "gold": [], "text": "Thus, at the approved dosage of darunavir-ritonavir, darunavir concentrations at the end of the dosing interval remain well above the concentration needed to inhibit replication of HIV strains (20; V. Sekar, S. Spinosa-Guzman, E. Lefebvre, and R. Hoetelmans, presented at the 16th International AIDS Conference, 2006)."}, {"generated": ["Clinical trial"], "gold": [], "text": "Safety was evaluated by clinical interview and physical examination and by laboratory assessment (blood counts, chemistry, CD4+ T-cell count, and HIV-1 RNA load) on days 0, 14, and 28."}, {"generated": ["Clinical trial"], "gold": [], "text": "No patient reported adverse events during the study, and all maintained an HIV-1 RNA load of <50 copies/ml at the end of the study."}, {"generated": ["Pharmacokinetics study of Darunavir"], "gold": [], "text": "Darunavir pharmacokinetics."}, {"generated": ["studies of clinical pharmacokinetic interactions"], "gold": [], "text": "In spite of this, studies of clinical pharmacokinetic interactions between antiretroviral agents and botanicals are scarce in the literature."}, {"generated": ["cohort study"], "gold": [], "text": "The variability in the effect of echinacea on darunavir pharmacokinetics we observed in this cohort may imply some degree of uncertainty in the CYP3A4 inductive/inhibitory potential of this herbal remedy."}, {"generated": ["Clinical trial or observation study"], "gold": [], "text": "We found, however, that E. purpurea was well tolerated, with no evident safety issue of concern."}, {"generated": ["In vivo study"], "gold": [], "text": "EGb 761\u00ae has no relevant effect on the in vivo activity of the major CYP enzymes in humans and therefore has no relevant potential to cause respective metabolic drug\u2013drug interactions."}, {"generated": ["None"], "gold": [], "text": "Ginkgo biloba extract is a popular herbal remedy used for a variety of disorders."}, {"generated": ["Not specified in given text"], "gold": [], "text": "Precipitation was done the same way without an internal standard for OME, 5-OH-OME, DEX, DOR), and MID assays, respectively."}, {"generated": ["Bioequivalence study"], "gold": [], "text": "Evaluation of phenotyping metrics followed the standard bioequivalence approach, with adjusted margins."}, {"generated": ["Drug administration"], "gold": [], "text": "Administration of EGb 761\u00ae 120\u00a0mg b.i.d."}, {"generated": ["Referenced study"], "gold": [], "text": "A maximum exposure was realized with a 240-mg EGb 761\u00ae daily dose, and exposure duration was sufficient to eventually induce CYPs, as steady state for EGb 761\u00ae components was reached, and 1\u00a0week is typically sufficient to achieve full induction [35]."}, {"generated": ["Referenced study"], "gold": [], "text": "The metrics used for CYP1A2 and CYP2C9 may be considered as fully validated [28]."}, {"generated": ["Clinical trial or observation study"], "gold": [], "text": "does not affect CYP2C19 activity when administered over an 8-day period."}, {"generated": ["Systematic review"], "gold": ["randomized controlled trials"], "text": "The aim of this study was to systematically review data regarding pharmacokinetic (PK)-pharmacodynamic (PD) parameters from randomized controlled trials relating to interactions between herbal medicines and warfarin."}, {"generated": ["Systematic review"], "gold": ["randomized controlled trials (RCTs)"], "text": "The aim of this article was to systematically review clinical data, including PK-PD parameters, from randomized controlled trials (RCTs) and to discuss interactions between herbal medicines and warfarin."}, {"generated": ["Two reviewers were involved in the study selection and data extraction using standard eligibility inclusion criteria."], "gold": [], "text": "The study selection and data extraction used standard eligibility inclusion criteria as determined by two reviewers."}, {"generated": ["In vitro"], "gold": [], "text": "marked circle, Unclear risk of bias; Minus (-) marked circle, High risk of bias."}, {"generated": ["in vivo"], "gold": ["in vivo study"], "text": "However, an in vivo study indicated that echinacea did not significantly affect the metabolism of drugs metabolized by CYP2C9 [47]."}, {"generated": ["In vitro, In vivo, Molecular docking studies"], "gold": [], "text": "(DOCX) Click here for additional data file."}, {"generated": ["Blood serum analysis of a patient"], "gold": [], "text": "She had no history of warfarin use, but warfarin was detected in her blood serum analysis."}, {"generated": ["research project or investigation"], "gold": [], "text": "The WSU Institutional Review Board reviewed and approved the study protocol and consent form prior to subject enrollment."}, {"generated": ["Clinical trial or observational study"], "gold": [], "text": "Vital signs (blood pressure, pulse, oxygen saturation) were obtained on every study day."}, {"generated": ["In vitro study or analysis"], "gold": [], "text": "The terminal elimination rate constant (\u03bb All statistical analyses were conducted using SAS (v. 9.2; SAS Institute)."}, {"generated": ["Discussion about the limitation in predicting herb\u2013drug interactions for herbal products"], "gold": [], "text": "This limitation applies particularly to the prediction of herb\u2013drug interactions, as herbal products are typically mixtures of multiple constituents that can alter ADME processes via multiple mechanisms."}, {"generated": ["Alternate study designs"], "gold": [], "text": "Alternate study designs, including silibinin predosing and multiple dosing of raloxifene, could provide further insight into interaction potential."}, {"generated": ["Design of study in drug development"], "gold": [], "text": "Design of drug molecules to avoid oxidative metabolism continues to emphasize the importance of conjugative metabolism in drug development."}, {"generated": ["In vitro"], "gold": [], "text": "Supporting Information Click here for additional data file."}, {"generated": ["Animal study"], "gold": [], "text": "However, multiple-dose combination of curcumin with gliclazide produced significantly greater reduction in percent blood glucose reduction at 3-, 4-, 6-, 8-, 10-, and 12-hour intervals after treatment in normal rats and rabbits when compared with gliclazide control."}, {"generated": ["Previously reported studies"], "gold": [], "text": "This effect of curcumin can be attributed due to one or more possible mechanisms as reported earlier."}, {"generated": ["systematic review"], "gold": [], "text": "In view of all the constraints of the existing literature, a comprehensive systematic review focusing on CBZ and overcoming the mentioned hurdles is warranted for healthcare professionals to make proper decisions."}, {"generated": ["Animal study (rabbits)"], "gold": [], "text": "Although honey was shown to decrease the oral bioavailability of CBZ in rabbits, it had no effect on the pharmacokinetic parameters of CBZ in human [63\u201365]."}, {"generated": ["No study described"], "gold": [], "text": "Caution should also be paid for beverage containing alcohol."}, {"generated": ["randomized double-blinded control trial"], "gold": ["a randomized double-blinded control trial"], "text": "In a randomized double-blinded control trial, Xiao-yao-san increased the incidence of CBZ-related side effects including dizziness, blurred vision, skin rash, and nausea in patients with major depression or bipolar disorder."}, {"generated": ["Research Article"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["Survey or observational study"], "gold": [], "text": "Fifty percent of the informants used herbal medicines alongside their prescription drugs."}, {"generated": ["Discussion"], "gold": [], "text": "In identifying these possible interactions, we have highlighted the need for healthcare professionals to promote a proactive monitoring of patients' use of herbal medicines."}, {"generated": ["Table from a study"], "gold": [], "text": "A summary of the background characteristics of the interviewed patients is given in Table 1."}, {"generated": ["Observational study"], "gold": [], "text": "This is possibly because the highest number of patients with type-2 diabetes fell within that age group."}, {"generated": ["Tabular summary"], "gold": [], "text": "Tabular summary of the pharmacological management of the patients' based on their prescribed hypoglycaemic agents."}, {"generated": ["Discussion"], "gold": [], "text": "Healthcare practitioners who are aware of their patients' use of herbal medicines and its identity can more easily monitor them for any possible interactions using available information, such as that presented in Tables 3, 4."}, {"generated": ["Scientific article"], "gold": [], "text": "Herb\u2013drug interactions strongly challenge the clinical combined application of herbs and drugs."}, {"generated": ["In vitro experiment"], "gold": [], "text": "There was no significant difference between BNPP (68 \u00b5g/mL) and PNS (150 \u00b5g/mL)."}, {"generated": ["Descriptive"], "gold": [], "text": "Liver drug enzymes are the common sites of drug interaction in human."}, {"generated": ["Study by Furlong et al."], "gold": [], "text": "The influence test for PON was conducted by the method of Furlong et al."}, {"generated": ["research work"], "gold": [], "text": "The present work provides an insight into the mechanism exploration governing HDI between aspirin and PNS."}, {"generated": ["research study"], "gold": [], "text": "conceived and designed the whole experiments."}, {"generated": ["In vitro"], "gold": [], "text": "** and *** denoted result significantly different from that of the control group (p < 0.01 and p < 0.001, respectively)."}, {"generated": ["None"], "gold": [], "text": "However, there is hardly any data on the pharmacological safety of these two herbal medicines."}, {"generated": ["Experimental"], "gold": [], "text": "To demonstrate possible influences on aryl hydrocarbon receptor (AhR), another important transcription factor regulating e.g., CYP1A, we also tested whether Samento can activate AhR and found only a minor effect compared to the positive control omeprazole (Figure 4B)."}, {"generated": ["in vitro study"], "gold": ["in vitro"], "text": "This study, therefore, scrutinized in vitro whether Samento and Banderol can inhibit the activity or induce the expression of important drug metabolizing enzymes and drug transporters."}, {"generated": ["Previously published study"], "gold": [], "text": "BCRP inhibition was tested by flow cytometry using pheophorbide A as a specific BCRP substrate in MDCKII-BCRP cells compared to the parental cell line MDCKII as described previously [24]."}, {"generated": ["In vitro assay"], "gold": [], "text": "Therefore, Samento and Banderol were tested up to a dilution of 1% in the induction assay."}, {"generated": ["Previously published study"], "gold": [], "text": "Data were evaluated as described previously [28]."}, {"generated": ["In vitro"], "gold": [], "text": "* p < 0.05, ** p < 0.01."}, {"generated": ["Laboratory experiment"], "gold": [], "text": "Results of the reporter gene assays."}, {"generated": ["Laboratory experiment"], "gold": [], "text": "(a) Concentration-dependent effect of Samento and the positive control rifampicin (insert) on pregnane x receptor (PXR) activity."}, {"generated": ["In vitro experiment"], "gold": [], "text": "Effects of Samento (0.033\u20131%) and the positive control rifampicin (20 \u00b5M) on the protein expression of P-glycoprotein (P-gp) after four days of exposure."}, {"generated": ["Laboratory experiment"], "gold": [], "text": "Effect of Samento on CYP2J2 mRNA decay in LS180 cells."}, {"generated": ["Experimental"], "gold": [], "text": "Expression of CYP2J2 mRNA was quantified by RT-PCR and results normalized to \u03b22mg and to t = 0."}, {"generated": ["Drug interaction study"], "gold": [], "text": "Drug interactions may occur between woohwangcheongsimwon suspension and bupropion."}, {"generated": ["No study described in this sentence."], "gold": [], "text": "Its original formulation was in a tablet form."}, {"generated": ["None"], "gold": [], "text": "It has been officially listed in the Korean Pharmaceutical Codex for a long time and an aqueous suspension has recently been developed for convenient administration [1]."}, {"generated": ["Clinical trial or study"], "gold": [], "text": "Subjects were also asked to abstain from taking prescription and over the counter medications for 2 weeks before and during the study period."}, {"generated": ["CYP2B6 genotyping performed by pyrosequencing of PCR products"], "gold": [], "text": "CYP2B6 genotyping  CYP2B6 genotyping was performed by pyrosequencing of polymerase chain reaction (PCR) products as described previously [13]."}, {"generated": ["clinical trial"], "gold": [], "text": "Safety monitoring was performed throughout the study."}, {"generated": ["Research Article"], "gold": [], "text": "Geometric means were calculated for the AUC(0,\u221e), Cmax and so on of bupropion and 4-hydroxybupropion."}, {"generated": ["Clinical trial or observation"], "gold": [], "text": "No clinically significant alterations in blood pressure, heart rate or body temperature were observed."}, {"generated": ["Clinical trial or investigation"], "gold": [], "text": "Go to: Discussion  In this study, we examined the CYP2B6 inhibitory effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion."}, {"generated": ["Research article"], "gold": [], "text": "The overexpression or somatic mutations of tyrosine kinases are dysregulated in various malignancies [3]."}, {"generated": ["Animal study"], "gold": [], "text": "The APG-pretreated rats showed significant inhibition of the Pgp/MDR1 protein, that is 65.38% and 69.90% inhibition, respectively, as compared to DAS alone (p < 0.05)."}, {"generated": ["Investigation"], "gold": [], "text": "The inhibitory potential of APG on BCRP/ABCG2 protein expression was investigated and shown in Figure 5A,B."}, {"generated": ["Animal study"], "gold": [], "text": "The APG-pretreated rats showed significant inhibition of the BCPR/ABCG2 protein that is (66.77% and 41.06% inhibition, respectively) as compared to DAS only (p < 0.05)."}, {"generated": ["research study"], "gold": [], "text": "The purpose of the current study was to determine whether or not APG has a pharmacokinetic interaction with DAS, and if so, how they would interact."}, {"generated": ["Pharmacokinetic study"], "gold": [], "text": "The radical alteration in the pharmacokinetic parameters of DAS 25 mg/kg P.O."}, {"generated": ["Animal study"], "gold": [], "text": "on the 7th day, 2\u2009h after APG 40 mg/kg administration, and Group IV was administered with APG 40 mg/kg for 7 days."}, {"generated": ["In vitro and in vivo studies"], "gold": [], "text": "and M.A.A."}, {"generated": ["Not specified in the given text"], "gold": [], "text": "; supervision, K.M.A."}, {"generated": ["In vitro"], "gold": [], "text": "All results are presented as the average \u00b1 SD."}, {"generated": ["Theory or hypothesis"], "gold": [], "text": "Phytochemical-mediated modulation of cytochrome P-450 (CYP) activity may underlie many herb-drug interactions."}, {"generated": ["The study describes a potential clinical relevance of herb-mediated changes in CYP activity in a specific population"], "gold": [], "text": "If so, herb-mediated changes in CYP activity may take on greater clinical relevance in this population."}, {"generated": ["Discussion of the potential risks of concomitant use of botanical supplements and prescription medications"], "gold": [], "text": "Concomitant ingestion of botanical supplements with prescription medications, therefore, should be strongly discouraged in the elderly."}, {"generated": ["Clinical trial"], "gold": [], "text": "The purpose of this study was to evaluate the effect of SC extract supplementation on quadriceps muscle strength (QMS) and lactate at rest in adult women."}, {"generated": ["Hypothesis"], "gold": [], "text": "Our first hypothesis is that the supplementation of SC extract in humans can increase muscle strength."}, {"generated": ["No information given in the provided text"], "gold": [], "text": "The subject\u2019s knee joint center, measured using the femoral epicondyles as a joint center reference, was aligned with the axis of the isokinetic dynamometer."}, {"generated": ["N/A"], "gold": [], "text": "Plasma samples were obtained by centrifugation and stored at \u221280 \u00b0C."}, {"generated": ["Clinical trial"], "gold": [], "text": "The mean SC extract supplementation and placebo compliance were 97.3% (90.2\u2212100%) in the SC group and 95.8% (86.7\u2013100%) in the placebo group."}, {"generated": ["Observational study"], "gold": [], "text": "Resting lactate level was measured at baseline and after 12 weeks, and results are presented in Figure 2."}, {"generated": ["research article"], "gold": [], "text": "have shown the association between high lactate production and reduced oxidative metabolism [47]."}, {"generated": ["Experimental"], "gold": [], "text": "These interactions were caused by pregnane\u2010X\u2010receptor (PXR) activation."}, {"generated": ["comprehensive pharmacokinetic interaction study"], "gold": [], "text": "This statement was provided even before another comprehensive pharmacokinetic interaction study was published, where no clinically relevant interactions were found for seven test drugs in concomitant application with a low\u2010hyperforin SJW extract (Zahner et al., 2019)."}, {"generated": ["high quality clinical data"], "gold": [], "text": "Based on the high quality clinical data, pharmacoepidemiology methods and bioinformatics or data mining could be adopt for further identification of clinical meaningful herb-drug interactions in cancer therapies."}, {"generated": ["systematic reviews", "meta-analysis"], "gold": [], "text": "Although systematic reviews and meta-analysis of Lingzhi and Yunzhi as an adjunct for cancer treatment have been performed [8\u201310], these reviews mostly focused on clinical outcomes with no mechanistic explanations for the potential beneficial or harmful interactions."}, {"generated": ["systematic reviews", "meta-analysis"], "gold": [], "text": "Although systematic reviews and meta-analysis of Lingzhi and Yunzhi as an adjunct for cancer treatment have been performed [8\u201310], these reviews mostly focused on clinical outcomes with no mechanistic explanations for the potential beneficial or harmful interactions."}, {"generated": ["Summary of a process"], "gold": [], "text": "Figure\u00a01 summarizes the process of database searching and literature selection."}, {"generated": ["recent study"], "gold": [], "text": "Notably, a recent study found that such synergistic effect may be due to the inhibition of tumor metabolism via down-regulating Warburg-related proteins and restoration of the gut dysbiosis induced by paclitaxel [97]."}, {"generated": ["In vitro"], "gold": [], "text": "a."}, {"generated": ["Summary of a scientific article"], "gold": [], "text": "In summary, the aforementioned outcomes suggest that medicinal mushrooms have great potential to ameliorate the adverse effects of chemotherapeutic drugs in clinical settings."}, {"generated": ["Table from a research article"], "gold": [], "text": "Table S4."}, {"generated": ["In vitro"], "gold": [], "text": "Not applicable."}, {"generated": ["studies"], "gold": [], "text": "The metabolic activity of CYP2D6 was suggested to be associated with the long-term outcomes in breast cancer, although the studies are inconsistent [35]."}, {"generated": ["Observational study"], "gold": [], "text": "The significant inter-individual variability of CYP2D6 activity due to genetic polymorphisms was mitigated by the use of pooled microsomes from 50 donors [41]."}, {"generated": ["In vitro study"], "gold": ["in vitro"], "text": "Dextromethorphan in vitro inhibition profiles of CYP2D6 by reference inhibitor: Quinidine (0.1-1-2-5-10-100 \u03bcM)."}, {"generated": ["No study described"], "gold": [], "text": "To our knowledge, there is no available information regarding pharmacokinetic interactions between captopril and H. sabdariffa."}, {"generated": ["None"], "gold": [], "text": "The loss of body fluid was compensated by administrating 1.0\u2009mL saline solution (p.o.)"}, {"generated": ["Within-run accuracy and precision study"], "gold": [], "text": "The within-run accuracy and precision of captopril analysis ranged from 1.56% to 14.38% (Table 3)."}, {"generated": ["In vitro or in vivo study (animal model)"], "gold": [], "text": "In selectivity testing, six rats plasma was used."}, {"generated": ["Experiment"], "gold": [], "text": "In this experiment, we used 2-4-dibromoacetophenone as a derivatization agent to prevent the sulfhydryl group in captopril from binding to plasma sulfhydryl groups."}, {"generated": ["Reference"], "gold": [], "text": "The reaction was then stopped by adding formic acid [17]."}, {"generated": ["Two weeks study"], "gold": [], "text": "Two weeks of coadministration of H. sabdariffa extract is sufficient enough to affect the GSH level or the expression of the PEPT1 transporter."}, {"generated": ["Publication"], "gold": [], "text": "2016; Eng et\u00a0al."}, {"generated": ["Publication"], "gold": [], "text": "2016)."}, {"generated": ["clinical"], "gold": ["clinical study"], "text": "Statistical analysis of results obtained from clinical study was performed using Student\u2019s paired t-test."}, {"generated": ["research study"], "gold": [], "text": "The results suggest that the herb-drug interaction between GLT and AC might occur when they were co-administered."}, {"generated": ["The article discusses a study investigating the pharmacokinetics and pharmacodynamics of a novel small molecule inhibitor of the autophagy-lysosome pathway in rats and mice. The study was designed as a multiple-dose, randomized, crossover study in rats and a single-dose study in mice. The findings suggest that the inhibitor exhibits dose-dependent inhibition of autophagy in both species, with no significant differences in pharmacokinetics between rats and mice. These results may have implications for the development of therapeutic strategies targeting the autophagy-lysosome pathway in various diseases."], "gold": [], "text": "HOW MIGHT THIS CHANGE CLINICAL PHARMACOLOGY OR TRANSLATIONAL SCIENCE?"}, {"generated": ["In vitro"], "gold": [], "text": "(n\u00a0=\u00a06)."}, {"generated": ["Animal study"], "gold": [], "text": "wrote the manuscript."}, {"generated": ["None"], "gold": [], "text": "Eugenia jambolana (EJ) is an Indian traditional herb widely used for the treatment of diabetes mellitus."}, {"generated": ["pharmacodynamic"], "gold": ["pharmacodynamic study"], "text": "Despite low levels of SITA, the combination demonstrated a significant reduction in blood glucose level when compared with individual drug and individual extract administered groups during pharmacodynamic study."}, {"generated": ["Laboratory experiment"], "gold": [], "text": "Dried seed of Eugenia jambolana were powdered and used for preparation of aqueous extract by using the double maceration technique."}, {"generated": ["Not specified"], "gold": [], "text": "After seven days, the extract was filtered and the filtrate was stored in refrigerator until next processing."}, {"generated": ["Not specified in the given text"], "gold": [], "text": "It was filtered and the filtrate obtained in this step was mixed with the previous filtrate."}, {"generated": ["Laboratory study"], "gold": [], "text": "Glucose level was determined using GOD-POD Erba diagnostic kits."}, {"generated": ["In vitro and in vivo"], "gold": [], "text": "3a and b)."}, {"generated": ["Theoretical"], "gold": [], "text": "The underlying mechanism of diabetes that contributes to liver damage is the combination of increased oxidative stress and an aberrant inflammatory response."}, {"generated": ["In vitro and in vivo study"], "gold": [], "text": "*significantly different from normal group, # significantly different from diabetic control group at p\u00a0<\u00a00.001."}, {"generated": ["In vitro and in vivo study"], "gold": [], "text": "*significantly different from normal group, # significantly different from diabetic control group at p\u00a0<\u00a00.001."}, {"generated": ["Clarified the effect of oral administration of A. officinarum on indomethacin's pharmacokinetics"], "gold": [], "text": "Our results first clarified that oral administration of A.\u00a0officinarum produced significant alterations in the pharmacokinetic parameters of indomethacin."}, {"generated": ["excretion study"], "gold": [], "text": "A.\u00a0Officinarum could accelerate the excretions of indomethacin and its three metabolites in the bile and feces of rats in the excretion study."}, {"generated": ["Laboratory experiment"], "gold": [], "text": "Tissue homogenates were treated by the same method as plasma sample preparation except dilution process."}, {"generated": ["Animal experiment"], "gold": [], "text": "And other experiments were divided into 2 groups: model group and M-AOE group, with six rats in each group."}, {"generated": ["No specific study type mentioned. This text describes the collection of urine and feces at specific time intervals after administration."], "gold": [], "text": "Urine and feces were collected 0\u20136\u00a0h, 6\u201318\u00a0h and 18\u201328\u00a0h after administration."}, {"generated": ["Method validation study"], "gold": [], "text": "The method was fully validated in compliance with the U.S. Food and Drug Administration (USFDA) guidelines for bioanalytical method validation, including selectivity, matrix effect, linearity, recovery, accuracy and precision, dilution integrity, and stability evaluations."}, {"generated": ["In vitro/in vivo study"], "gold": [], "text": "Therefore, the protective effect of A.\u00a0officinarum on indomethacin-induced gastric injury might also be through the changes of pharmacokinetics for indomethacin and its metabolites to exert."}, {"generated": ["Model study"], "gold": [], "text": "In our study, the changing trends in the plasma concentration-time curves of indomethacin in S-AOE and M-AOE groups were similar to those in model group shown in Fig."}, {"generated": ["In vitro"], "gold": [], "text": "1)."}, {"generated": ["previously conducted study"], "gold": [], "text": "[7] previously showed that administration of 375 ml wine did not result in thrombin times (TTs) outside the therapeutic range, which suggested that a moderate intake of alcohol occasionally may be acceptable during anticoagulant therapy."}, {"generated": ["Anecdotal observation"], "gold": [], "text": "In China, Gouqizi is a popular component of the daily diet, making the prohibition of its consumption in patients taking warfarin difficult to implement."}, {"generated": ["survey or study"], "gold": [], "text": "Due to public concern regarding the risk of bleeding during treatment with warfarin, as well as the uneasy relationship between allopathic doctors and their patients, no more than 10% of patients with atrial fibrillation take warfarin in China [5]."}, {"generated": ["Clinical trial"], "gold": [], "text": "However, a daily Gouqizi dose of 6 g (dosing recommended by Chinese Pharmacopoeia) for 3 days did not enhance the effects of warfarin in three patients with prosthetic heart values who were concomitantly taking warfarin."}, {"generated": ["Interaction study"], "gold": [], "text": "The interaction study of warfarin and Lycium barbarum L.  Methods  This project about the interaction study of warfarin and Lycium barbarum L. is approved by Fujian Medical University Union Hospital ethics committee (NO: 2015KY002)."}, {"generated": ["In vitro"], "gold": [], "text": "7.2."}, {"generated": ["15 day study"], "gold": [], "text": "One brief 15 day study reported a significant increase in total cholesterol among hypertensive patients administered HS [18]."}, {"generated": ["Description of study not provided"], "gold": [], "text": "In addition, electrolyte levels generally are not effected by ingesting HS extracts despite its diuretic effects."}, {"generated": ["In vitro or computational simulation"], "gold": [], "text": "Conversely, S. sphenanthera at a clinically\u2010relevant dose results in a predicted three\u2010fold increase in bosutinib systemic exposure."}, {"generated": ["discussion about the need for a reliable approach to predict herb-drug interactions"], "gold": [], "text": "21 Clearly, a reliable and systematic approach to predict these herb\u2013drug interactions is needed."}, {"generated": ["In vitro and in vivo studies"], "gold": [], "text": "Go to: 2."}, {"generated": ["In vitro"], "gold": [], "text": "2.1.2."}, {"generated": ["extensive in vitro study"], "gold": ["in vitro study"], "text": "An extensive in vitro study showed that recombinant CYP2C8 enzyme (supersomes) was less sensitive than human liver microsomes (HLM) to identify potential mechanism\u2010based inhibitors and was characterised by a high lot\u2010to\u2010lot variability."}, {"generated": ["N/A"], "gold": [], "text": "The reaction was initiated by the addition of NADPH and terminated by placing the tubes on a cooling block (Selleckchem, Houston, TX, USA)."}, {"generated": ["Theoretical analysis"], "gold": [], "text": "The competitive, noncompetitive and mixed\u2010inhibition models (Equations 1\u20133, respectively) were considered."}, {"generated": ["Theoretical discussion"], "gold": [], "text": "Theoretically, the discrimination between competitive and noncompetitive inhibitions is not critical when concentrations of substrates are much lower than their K m values, which is often the case in the clinical setting."}, {"generated": ["Inter-correlation study"], "gold": [], "text": "Inter\u2010correlation between tissue composition and log P also had a significant impact on the estimation of K p (tissue\u2010to\u2010plasma partition coefficients)."}, {"generated": ["clinical trials"], "gold": ["trial designs"], "text": "PBPK simulations were also carried out to evaluate the capability of PBPK models of Schisandra lignans in predicting the extent of interactions with midazolam and tacrolimus with trial designs as detailed in Table 3."}, {"generated": ["Research Article"], "gold": [], "text": "MBI, mechanism\u2010based inhibition Go to: 4."}, {"generated": ["research article"], "gold": [], "text": "Another limitation of the current study is the reliance on the assumption that Schisandra lignans are solely responsible for the interactions with CYP substrates."}, {"generated": ["None"], "gold": [], "text": "Ginkgo biloba is available as an over-the-counter drug and reported to cause haemorrhage when coadministered with other antiplatelet agents."}, {"generated": ["Experimental"], "gold": [], "text": "We also monitored the effects of Danshen/Gegen on the activities and mRNA and protein expression levels of VKOR and TM (for pharmacodynamic analysis)."}, {"generated": ["Authentication of herbs"], "gold": [], "text": "The raw herbs were morphologically authenticated by an in-house herbalist and chemically by the thin layer chromatography in accordance with the Chinese Pharmacopoeia 2005 [36]."}, {"generated": ["Methodology"], "gold": [], "text": "The linear gradient elution was carried out as follows with a total running time of 90\u00a0min: solvent A was kept at 5\u00a0% for the first 5\u00a0min, and then increased to 10, 17, 35 and 90\u00a0% in the next 13, 12, 10 and 30\u00a0min, respectively, then returned to 5\u00a0% in 5\u00a0min and equilibrated for 15\u00a0min before the next injection."}, {"generated": ["In vitro experiment"], "gold": [], "text": "Compared with the vehicle control group, there was a significant increase of 420\u00a0% (P\u00a0<\u00a00.001) in the mRNA expression ratio of CYP2C6 in the positive control group."}, {"generated": ["In vitro or in vivo experiment"], "gold": [], "text": "Furthermore, no inductive effects were observed in the mRNA expression level of CYP2C6 for both doses of Danshen compared with the vehicle control group."}, {"generated": ["In vitro and in vivo study"], "gold": [], "text": "*P\u00a0<\u00a00.05; **P\u00a0<\u00a00.01; ***P\u00a0<\u00a00.001, compared with the vehicle control group."}, {"generated": ["Animal study"], "gold": [], "text": "The results of our previous study showed that the administration of a DFG-warfarin combination led to a reduction in the warfarin plasma concentration and PT time of rats [23, 32]."}, {"generated": ["current study"], "gold": [], "text": "Taken together with the results of the current study, it seems clear that these effects could be attributed to the Gegen present in DFG."}, {"generated": ["Predictive models (algorithms) used for warfarin dose prediction"], "gold": [], "text": "Algorithms that integrate the relevant genetic and physical factors into comprehensive, individualized predictive models were used to predict warfarin dose [54]."}, {"generated": ["Experimental"], "gold": [], "text": "Furthermore, CYP1A-, CYP2C- and CYP3A-inducing agents were found in the ethyl acetate extract, but not in the aqueous extract of Danshen [57]."}, {"generated": ["in vitro and in vivo study by Yueng"], "gold": ["in vitro and in vivo"], "text": "This finding is also supported by Yueng\u2019s study, where the major tanshinone components rather than the aqueous extract of Danshen showed effects on warfarin hydroxylation in vitro and in vivo [58]."}, {"generated": ["Research article"], "gold": ["in vivo effects"], "text": "In our study, although SAB was used as a major component of the Danshen granules, the in vivo effects were very different to those observed in cells because of the poor absorption and bioavailability of SAB."}, {"generated": ["In vitro and in vivo"], "gold": ["in vitro", "in vivo"], "text": "All of these factors could therefore be considered as potential explanations for the discrepancies observed between the in vitro and in vivo results."}, {"generated": ["Clinical trial"], "gold": [], "text": "There was no difference in the toxicity profile of hormone therapy with ginkgo biloba use in women with early stage breast cancer."}, {"generated": ["Publication"], "gold": [], "text": "Sample preparation was based on the publication by (Beer et al."}, {"generated": ["Pharmacokinetic study"], "gold": [], "text": "The extraction recovery from human plasma was considered acceptable with a mean recovery of greater than 88% for each analyte."}, {"generated": ["Chromatography analysis"], "gold": [], "text": "No endogenous peaks were identified in the extracted ion chromatograms that would cause interference with drug quantitation."}, {"generated": ["Observational study"], "gold": [], "text": "The 48 (80%) women who had received adjuvant chemotherapy were a mean of 37\u2009months (range 4\u2013113) from completion of chemotherapy."}, {"generated": ["Research gap"], "gold": [], "text": "Little is known of the effect of most tropical medicinal herbs on the metabolic capacity of CYP isoenzymes."}, {"generated": ["Experimental investigation"], "gold": [], "text": "Multiple reaction monitoring (MRM) mode using positive ion mode."}, {"generated": ["N/A"], "gold": [], "text": "Fifty percent inhibitory concentration (IC   where A\u00a0=\u00a0log of concentration of aqueous extract of herb in the incubations."}, {"generated": ["research report"], "gold": [], "text": "Though we did not report any inhibition of CYP isoenzymes by Allium sativum, the discrepancies in these reports and ours may be due to the extraction procedure, assay method, concentration and type of the extract used and enzyme sources."}, {"generated": ["Research study"], "gold": [], "text": "In this study, aqueous extract of oven\u2010dried Allium sativum bulbs was used."}, {"generated": ["In vitro study"], "gold": [], "text": "Aqueous extract of Moringa oleifera leaves showed weak inhibition of CYP1A2 and CYP2C9."}, {"generated": ["et al."], "gold": [], "text": "Strandell et\u00a0al."}, {"generated": ["Publication"], "gold": [], "text": "(2000)."}, {"generated": ["Patented polyherbal formulation developed in India"], "gold": [], "text": "Ltd., Varanasi, India) is a patented polyherbal formulation developed to manage menopause symptoms that can be taken along with other allopathic medicines."}, {"generated": ["In vitro"], "gold": [], "text": "34860-2.5L-R) and ammonium acetate (catalog No."}, {"generated": ["Experimental"], "gold": [], "text": "The following formula determines the half-maximal inhibitory concentration (IC SRM Medical College Hospital and Research Centre and SRM Institute of Science and Technology, Kattankulathur ethics committees approved the protocol (approval No."}, {"generated": ["Volunteer selection for a study"], "gold": [], "text": "Volunteers were excluded if they had any clinically significant history or presence of a cardiovascular, pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, or neurologic disease/disorder."}, {"generated": ["Clinical trial"], "gold": [], "text": "The selected volunteers were randomized to placebo (inert substitute for a treatment or intervention) or MenoAct851 formulation (500 mg BID for 14 days in double-blind fashion) groups."}, {"generated": ["Clinical trial"], "gold": [], "text": "Double-blinded treatments were allocated using sequentially numbered drug containers."}, {"generated": ["In vitro"], "gold": [], "text": "Values are expressed as mean (SD)."}, {"generated": ["In vitro experiment"], "gold": [], "text": "(B) Plasma obtained from the volunteer received single oral dose of 40 mg simvastatin."}, {"generated": ["Concept"], "gold": [], "text": "Drug interactions can be considered illnesses by themselves."}, {"generated": ["Publication"], "gold": [], "text": "Object name is PGPM-14-963-g0003.jpg Figure 3  Drug interactions and drug \u2013 lifestyle reported by the personalized prescription software."}, {"generated": ["clinical trial or study"], "gold": [], "text": "All subjects completed the study and no adverse events related to either of the herbal medicines or warfarin were reported."}, {"generated": ["Study or research group"], "gold": [], "text": "Gorski et al."}, {"generated": ["Research article"], "gold": [], "text": "The reason for the discrepancy with previous studies remains unclear."}, {"generated": ["Laboratory experiment"], "gold": [], "text": "Key phytochemicals were individually assessed for their impact on CYP1A2 activity."}, {"generated": ["N/A"], "gold": [], "text": "The resulting liquor was suction-filtered through type 1 Whatman filter paper and stored in a sealed darkened glass container."}, {"generated": ["Screening study"], "gold": [], "text": "[15] to screen natural products for cytochrome P450 inhibition potential with a particular emphasis on the P450 enzymes, CYPs 1A1, 1A2, 1B1, 3A4 and 2D6."}, {"generated": ["In vitro"], "gold": [], "text": "[35]."}, {"generated": ["Research article"], "gold": [], "text": "Structures of phytochemicals identified in the aqueous extract of H. verticillata (aerial, dried)."}, {"generated": ["Pharmacokinetic study"], "gold": [], "text": "The pharmacokinetic data revealed that curcumin-treated animals had significantly (p \u2264 0.05) higher area under the plasma concentration-time curve and area under the first moment of plasma drug concentration-time curve."}, {"generated": ["Title of the study is 'Worse than the Disease?' but no specific information about the study type is provided in the given text."], "gold": [], "text": "Worse than the Disease?"}, {"generated": ["Naturopathic literature"], "gold": [], "text": "The naturopathic literature from which most information about rashes caused by Lomatium is drawn do not indicate a well-studied treatment of the rash aside from supportive care and cessation of Lomatium ingestion."}, {"generated": ["Case report"], "gold": [], "text": "In our patient, the rash was refractory to glucocorticoids and only resolved once her exposure to the extract ceased, although antihistamines were helpful to reduce pruritis."}, {"generated": ["Proposed research"], "gold": [], "text": "To explore more, we would like to investigate the interactions between OS and selected single herbs from these Wen Bing formulas."}, {"generated": ["Not applicable"], "gold": [], "text": "A commercially available, standardized and purified Radix Scutellariae extract (RS) was obtained from Shanghai U-sea Biotech Co., Ltd. (Shanghai, China) with a batch number of 110208 and a quality of control standard number of WS-10001-(HD-0989)-2002."}, {"generated": ["Animal study"], "gold": [], "text": "At 30\u202fmin following the 8PM dose on Day 5, the rats were anesthetized and about 10\u202fmL of blood were collected from rats\u2019 inferior vena for determination of antiviral activity."}, {"generated": ["Study describing the suppression of OSA formation rate by herb/herbal components"], "gold": [], "text": "The formation rate of OSA could be significantly suppressed by all the herb/herbal components."}, {"generated": ["In vitro"], "gold": [], "text": "S8)."}, {"generated": ["research study"], "gold": [], "text": "In our current study, a screening platform based on microsomes, enzymes, cells and influenza viruses have for the first time been developed and utilized to screen potential interaction between OS and anti-influenza herb/herbal components."}, {"generated": ["Theoretical analysis"], "gold": [], "text": "After such a normalization, the absolute z-score of an herb/herbal component effect on OS would be proportional to its level of HDI relevancy with OS."}, {"generated": ["N/A"], "gold": [], "text": "Radix Isatidis (Root of Isatis indigotica Fort., Banlangen)."}, {"generated": ["N/A"], "gold": [], "text": "Fructus Arctii (Fruit of Arctium lappa L., Niubangzi)."}, {"generated": ["Clinical study"], "gold": [], "text": "30%\u201370% of clinical breast cancer patients use natural products, which may increase the likelihood of drug interactions."}, {"generated": ["recent study"], "gold": [], "text": "A recent study has shown that the combined use of HES, PIP, and BV with TAM showed an enhanced anti-proliferative effect on MCF7 and T47D and can significantly increase cell apoptosis (Khamis et al., 2018)."}, {"generated": ["Research article"], "gold": [], "text": "When combined with TAM, it exhibits a significant synergistic inhibitory effect on MCF-7 and T-47D cell growth (Cho et al., 2010)."}, {"generated": ["Descriptive"], "gold": [], "text": "Mistletoe (Viscum album L.) derived medicinal preparations are widely used and registered as medicines in many European countries."}, {"generated": ["Publication"], "gold": [], "text": "The protective effect is dose-dependent (Rahate and Rajasekaran, 2015)."}, {"generated": ["Studies"], "gold": [], "text": "Studies have shown that just the monitoring of protein expression levels is insufficient in understanding transcription activity in vitro (Gord\u00e2n et al., 2009)."}, {"generated": ["Global Health Estimates 2000\u20132019 (GBD Diseases and Injuries, 2020)"], "gold": [], "text": "Communicable diseases are still leading causes of death and disability globally, according to WHO\u2019s Global Health Estimates 2000\u20132019 (GBD Diseases and Injuries, 2020)."}, {"generated": ["pharmacokinetic- and tissue distribution-based HDIs studies"], "gold": [], "text": "Consequently, GA and PCA were chosen as PCE tracer components in the pharmacokinetic- and tissue distribution-based HDIs studies."}, {"generated": ["Publication"], "gold": [], "text": "Approximately 60% of CIP is excreted in unchanged form into the urine (Vance-Bryan et al., 1990)."}, {"generated": ["Laboratory experiment"], "gold": [], "text": "The supernate was utilized for the quantification of GA, PCA, and CIP."}, {"generated": ["Observational study"], "gold": [], "text": "After co-administration of CIP and PCE, the PK changes of GA and PCA are displayed in Figures 3, 4, respectively."}, {"generated": ["Declaration"], "gold": [], "text": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, {"generated": ["In vitro and in vivo"], "gold": [], "text": "Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher."}, {"generated": ["In vitro"], "gold": [], "text": "Click here for additional data file."}, {"generated": ["Description of a study design or methodology"], "gold": [], "text": "The scale was anchored at each end with the labels \u201cnot at all\u201d (0 mm) and \u201cextremely\u201d (100 mm)."}, {"generated": ["Experimental"], "gold": [], "text": "However, the total AUC for CHO was lower in YM than PLC (13.3 vs. 15.00, p < 0.001)."}, {"generated": ["Previous study"], "gold": [], "text": "This increase is comparable with 24% increase found during low to moderate exercise intensities determined using an incremental protocol in our previous study [22]."}, {"generated": ["Research required"], "gold": [], "text": "However, further research is required to assess active ingredients of YM capsules and analyze their bioavailability following ingestion."}, {"generated": ["Animal study"], "gold": [], "text": "Food and water were supplied ad libitum."}, {"generated": ["survey"], "gold": [], "text": "showed that the practice of herbal co-medication with prescription drugs cut across various patient demographics, with 38% of respondents reporting concomitant herbal use [6]."}, {"generated": ["Anecdotal pieces of evidence"], "gold": [], "text": "Anecdotal pieces of evidence like this not only highlight the reality and severity of the consequences of HDIs, they underscore the importance of further studies to guide clinical decisions."}, {"generated": ["Autopsy report"], "gold": [], "text": "He was reported to have experienced a seizure before his death, and the toxicological autopsy results revealed subtherapeutic serum levels for both drugs."}, {"generated": ["Observational study"], "gold": [], "text": "Chronic use of ginseng on its own has been associated with manic psychosis [90]."}, {"generated": ["Scientific research article"], "gold": [], "text": "The pharmacological activities of kava have been attributed to kavalactones, which are concentrated in the rhizomes [96]."}, {"generated": ["No specific study mentioned"], "gold": [], "text": "Despite the general concern about its safety, kava is still popularly consumed for CNS benefits."}, {"generated": ["study in 18 health volunteers"], "gold": [], "text": "A study in 18 health volunteers did not show any clinically relevant interaction between kava and bromazepam [104]."}, {"generated": ["Description of study not provided"], "gold": [], "text": "Apart from CYP/P-gp induction, SJW mediates interactions through its serotonergic effects."}, {"generated": ["2-way, open-label crossover study"], "gold": ["open-label crossover study"], "text": "investigated the ability of SJW to interact with CYP3A4 in a 2-way, open-label crossover study of 21 healthy subjects using midazolam as the probe substrate."}, {"generated": ["In vitro"], "gold": [], "text": "This is especially important for drugs with a narrow therapeutic window."}, {"generated": ["Clinical case report"], "gold": [], "text": "At that time the serum creatinine level was 74.27\u2009\u00b5mol/L and was stable."}, {"generated": ["No specific study mentioned"], "gold": [], "text": "Contrary to this safety perception, herb\u2013drug interactions could lead to serious adverse effects."}, {"generated": ["No specific study mentioned"], "gold": [], "text": "Therapeutic drug monitoring is required as with other immunosuppressive drugs."}, {"generated": ["Previous studies"], "gold": [], "text": "Previous studies have shown the interactions between sirolimus and drugs that affect the activities of metabolizing enzymes and transporter proteins."}, {"generated": ["Clinical case report"], "gold": [], "text": "At that time the serum creatinine level was 74.27\u2009\u00b5mol/L and was stable."}, {"generated": ["Case report"], "gold": [], "text": "In this patient, we reported the possible effect of parsley juice on the level of sirolimus."}, {"generated": ["Clinical trial"], "gold": [], "text": "The AUC data showed statistically significant differences between group 1 and 2 and between groups 2 and 3 possibly suggest the herb-drug interaction between Epimedium sagittatum extract and sildenafil."}, {"generated": ["Discussion of a potential study"], "gold": [], "text": "Second, the pretreatment period of Epimedium sagittatum extract might have been too short to identify the possible herbal drug effect."}, {"generated": ["Not applicable"], "gold": [], "text": "The combined extraction solution was then evaporated to dryness."}, {"generated": ["In vitro"], "gold": [], "text": "Maxim extract are available from the authors."}, {"generated": ["Review article"], "gold": [], "text": "A more detailed description of the regulatory environment in Europe, as well as its practical effects, can be found in the Bilia and C\u00e9u Costas review [13]."}, {"generated": ["Descriptive analysis of patient treatment"], "gold": [], "text": "Though non-pharmacological treatments are the main therapy for these patients, application of analgetic drugs is common, often over years."}, {"generated": ["Literature review"], "gold": [], "text": "From the combined literature, a list of the most frequently occurring species was established."}, {"generated": ["Observational study"], "gold": [], "text": "They found a prevalence of 56.6%."}, {"generated": ["Spanish"], "gold": [], "text": "A Spanish study reports Aloe vera [37]."}, {"generated": ["No study mentioned"], "gold": [], "text": "Many potentially hepatotoxic herbs are not studied extensively enough to determine a safe daily dose."}, {"generated": ["Discussion of medical practice"], "gold": [], "text": "Short-term use of opioids for patients who cannot reach pain relief otherwise may occur, e.g., to bridge the time until surgical intervention."}, {"generated": ["Case report"], "gold": [], "text": "Another patient experienced liver injury after taking 500 mg leaf powder every 2\u20133 days as a laxative [117]."}, {"generated": ["No study described"], "gold": [], "text": "There are only food supplements available, with insufficiently defined product quality."}, {"generated": ["Discussion or debate about a study"], "gold": [], "text": "This is debated, and there are hints to possible beneficial effects [135]."}, {"generated": ["Monograph from The European Pharmacopoeia"], "gold": [], "text": "The European pharmacopoeia monographs pulverized dried bulbs of Allium sativum containing at least 0.45% allicin [154]."}, {"generated": ["Referenced study"], "gold": [], "text": "For the refined quantified dry extract, the ginkgolic acid content is limited to 5 ppm [154]."}, {"generated": ["In vitro"], "gold": [], "text": "The term \u201cginseng\u201d can be used for several drugs."}, {"generated": ["Research article or study"], "gold": [], "text": "Seong et al."}, {"generated": ["scientific opinion"], "gold": [], "text": "A scientific opinion of EFSA [196] from 2018 states that the common food consumption is safe, as there are only few cases of HILI associated with tea consumption despite the widespread use."}, {"generated": ["Observational study"], "gold": [], "text": "HILI could occur more frequently in these groups because of the combination of risk factors."}, {"generated": ["Animal study"], "gold": [], "text": "applied atorvastatin in rats after 3 weeks of drinking green tea or water."}, {"generated": ["Referenced study"], "gold": [], "text": "They favor CYP, as the patient could be unusually susceptible due to the individual genotype [207]."}, {"generated": ["in vitro"], "gold": [], "text": "Curcuminoids have been shown to inhibit CY3A4 and 2C9 in vitro [230]."}, {"generated": ["Human study"], "gold": [], "text": "Willow bark extract showed a smaller effect on platelet aggregation in humans than ASA [234]."}, {"generated": ["No study described"], "gold": [], "text": "The clinical significance of this phenomenon depends on individual susceptibility."}, {"generated": ["Discussion or Opinion Article"], "gold": [], "text": "It is important to make patients aware of the fact that plants can cause adverse effects and are not safe in every situation by being \u201cnatural\u201d."}, {"generated": ["Survey by Garcia-Alvarez"], "gold": [], "text": "Valerian, for example, is marketed in Germany, mainly as HMP, and, thus, possibly a great proportion of consumption was not included in the survey by Garcia-Alvarez [7]."}, {"generated": ["In vitro"], "gold": [], "text": "This may result in translation errors or assigning mentions to the wrong species, in some cases."}, {"generated": ["Thematic analysis of text"], "gold": [], "text": "Herb\u2013drug interactions (HDI) may affect clinical safety and efficacy via additive/synergistic or antagonistic interactions among the herbal components and drug molecules."}, {"generated": ["Description of study: Discussion of the potential interaction between herbs and drugs"], "gold": [], "text": "When these herbs and drugs are used together, pharmacodynamic HDI (either additive/synergistic) may occur."}, {"generated": ["Historical study"], "gold": [], "text": "This herb has been in use for diabetic treatment for almost two millennia [72]."}, {"generated": ["Findings from a research article"], "gold": [], "text": "These findings suggest further research in individuals with diabetes is required to determine the effect of the combination of gymnema tea and metformin on blood sugar levels."}, {"generated": ["Experimental"], "gold": [], "text": "Evidence supporting the interaction between Lycium and antidiabetics is experimental only."}, {"generated": ["Observational study"], "gold": [], "text": "Findings such as these suggest that Lycium may have an additive effect when used in combination with conventional antidiabetics [86]."}, {"generated": ["Discussion about the use of system-to-system or systems biology methodology in evaluating complex interactions"], "gold": [], "text": "System-to-system or systems biology methodology is a more appropriate model for the evaluation of more complex interactions but its use is often limited by the availability of the relevant chemical and pharmacological data, especially in complex herbal interventions."}, {"generated": ["The study described is not specified in the given text."], "gold": [], "text": "Conversely, it is important to keep in mind that these interactions may also present therapeutic benefits as a result of synergism which may lead to enhanced drug effects or reduced adverse reactions."}, {"generated": ["No specific study mentioned"], "gold": [], "text": "The internal standards codeine and betaxolol were of USP reference standard."}, {"generated": ["in vitro"], "gold": ["in vitro study"], "text": "In the in vitro study, Asafetida resin alcoholic extract inhibited the formation of DOR from DEX in a concentration dependent manner (Fig."}, {"generated": ["Laboratory experiment"], "gold": [], "text": "The activation was highest at 25\u00a0\u03bcg/ml concentration."}, {"generated": ["in vivo study"], "gold": ["vivo study"], "text": "The in vivo study was conducted on healthy human volunteers."}, {"generated": ["clinical"], "gold": ["clinical study"], "text": "Therefore, the clinical study was conducted to confirm the in vitro results."}, {"generated": ["research study"], "gold": [], "text": "In conclusion, the significant Asafetida inhibitory effect on CYP3A4 metabolic activity was an important finding of this study."}, {"generated": ["Observational study"], "gold": [], "text": "These may favor the occurrence of abemaciclib-related diarrhea, causing dose reductions and poor adherence and eventually negatively influencing patients' outcomes and quality of life."}, {"generated": ["Narrative description of a clinical case"], "gold": [], "text": "Moreover, the reckless pieces of information about possible effects of diet, such as fatigue and loose stools, elicited confusion in the patient."}], "FN": [{"generated": [], "gold": ["pharmacogenomics studies", "clinic study"], "text": "In the following, we reviewed pharmacogenomics studies, mainly from clinic study, on some important herb products that have been reported to have HDIs."}, {"generated": [], "gold": ["pharmacogenomics studies", "clinic study"], "text": "In the following, we reviewed pharmacogenomics studies, mainly from clinic study, on some important herb products that have been reported to have HDIs."}, {"generated": ["researchers are adopting the guidelines and opinions proposed for DDI studies"], "gold": ["DDI studies"], "text": "With the tremendous surge in the acceptance of and public interest in herbal medicinal remedies, researchers are adopting the guidelines and opinions proposed for DDI studies to study HDI."}, {"generated": [], "gold": ["In vivo distribution studies"], "text": "In vivo distribution studies are crucial in drug research as they can be performed to demonstrate the pharmacokinetic features of a drug [21, 22]."}, {"generated": [], "gold": ["in vitro study"], "text": "Statistical analyses were performed using GraphPad Prism This in vitro study indicated that combining nutraceuticals containing rooibos extracts with drugs metabolized by CYP2C8 and CYP3A4 could potentially alter the pharmacodynamics and safety of these drugs."}, {"generated": [], "gold": ["clinical studies"], "text": "Compared with the clinical studies in which significant induction of CYP3A4 by E. purpurea was found using midazolam as a CYP3A4 probe [11, 12], our study differed in formulation, dose and dosing regimen, which may explain the divergent outcome."}, {"generated": [], "gold": ["phase II clinical trials", "preclinical studies"], "text": "None of the aforementioned studies investigated the effects on drug-metabolizing enzymes of the type of extract (CAW) used in our preclinical studies and in our current phase I (NCT03929250, NCT03937908) and proposed phase II clinical trials investigating CAW as a botanical drug for cognitive decline."}, {"generated": [], "gold": ["phase II clinical trials", "preclinical studies"], "text": "None of the aforementioned studies investigated the effects on drug-metabolizing enzymes of the type of extract (CAW) used in our preclinical studies and in our current phase I (NCT03929250, NCT03937908) and proposed phase II clinical trials investigating CAW as a botanical drug for cognitive decline."}, {"generated": [], "gold": ["clinical studies"], "text": "Based on the centelloid content of CAW-R61J, we expect similar plasma concentrations for these compounds in our clinical studies using this extract."}, {"generated": [], "gold": ["surveys"], "text": "[1\u20133,8,9] Still other surveys indicate that herbal supplement usage is prevalent among patients taking prescription medications,[10\u201312] with many individuals greater than 65 years of age."}, {"generated": ["Clinical trial or study"], "gold": ["both arms"], "text": "On serial electrocardiograms the PR interval, QRS duration and corrected QT interval (QTc) were similar in both arms (S2 Table)."}, {"generated": [], "gold": ["clinical trial", "clinical trials"], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": [], "gold": ["clinical trial", "clinical trials"], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": [], "gold": ["inhibition kinetic study"], "text": "Furthermore, inhibition kinetic study (Dixon plot and Lineweaver-Burk plot) demonstrated that celastrol noncompetitively inhibited the UGT1A1-mediated 4-MU glucuronidation, and competitively inhibited UGT2B7-catalyzed 4-MU glucuronidation."}, {"generated": ["Systematic review"], "gold": ["randomized controlled trials"], "text": "The aim of this study was to systematically review data regarding pharmacokinetic (PK)-pharmacodynamic (PD) parameters from randomized controlled trials relating to interactions between herbal medicines and warfarin."}, {"generated": ["Systematic review"], "gold": ["randomized controlled trials (RCTs)"], "text": "The aim of this article was to systematically review clinical data, including PK-PD parameters, from randomized controlled trials (RCTs) and to discuss interactions between herbal medicines and warfarin."}, {"generated": [], "gold": ["trials"], "text": "For incomplete outcome data, seven trials [21\u201324, 26, 28, 29] reported detailed information regarding attrition by describing the number and reasons for withdrawal."}, {"generated": [], "gold": ["case reports"], "text": "Some studies pointed out such limitations, that is, that case reports often result in misleading conclusions for multiple reasons [39, 40]."}, {"generated": ["in vivo"], "gold": ["in vivo study"], "text": "However, an in vivo study indicated that echinacea did not significantly affect the metabolism of drugs metabolized by CYP2C9 [47]."}, {"generated": ["randomized double-blinded control trial"], "gold": ["a randomized double-blinded control trial"], "text": "In a randomized double-blinded control trial, Xiao-yao-san increased the incidence of CBZ-related side effects including dizziness, blurred vision, skin rash, and nausea in patients with major depression or bipolar disorder."}, {"generated": ["in vitro study"], "gold": ["in vitro"], "text": "This study, therefore, scrutinized in vitro whether Samento and Banderol can inhibit the activity or induce the expression of important drug metabolizing enzymes and drug transporters."}, {"generated": [], "gold": ["in vitro"], "text": "IC In conclusion, Samento and Banderol exhibit a completely different in vitro profile as perpetrators in herb\u2013drug interactions."}, {"generated": [], "gold": ["reports"], "text": "The first clinically relevant reports of preparations of St. John's wort (SJW), a herbal medicine with anti\u2010depressant effects, interacting with other drugs, altering their bioavailability and efficacy, were published about 20 years ago."}, {"generated": [], "gold": ["in vitro", "in vivo"], "text": "SJW extracts as well as isolated constituents (hyperforin, hypericin, or flavonoids) have been investigated in vitro and in vivo for their interactions with a variety of potentially relevant targets for depression."}, {"generated": [], "gold": ["in vitro", "in vivo"], "text": "SJW extracts as well as isolated constituents (hyperforin, hypericin, or flavonoids) have been investigated in vitro and in vivo for their interactions with a variety of potentially relevant targets for depression."}, {"generated": [], "gold": ["preclinical studies"], "text": "Reduce T cell apoptosis and caspase 3 activity through downregulating Bax expression in T cells [170] Increase in efficacy and survival [20], better symptomatic relief [20] increase in T cells count (CD4, CD4/CD8) [20] Better symptomatic relief [141] and increase appetite [144] Less reduction in WBC (CD3+, CD4+ T cells, NK cells) [141, 144], platelets [144] Pharmacodynamic interactions between medicinal mushrooms and cytotoxic drugs in preclinical studies Increase in tumor inhibition effect [83, 84, 98] and survival time [63] Less decrease in WBC [83, 84, 145], platelets [83] and other bone marrow cells [84] Greater recovery rate from intestinal damage caused by 5-FU [173] Increase in survival [67], cytotoxicity and inhibit metastasis [111] Reduce immunosuppression (reduce the decrease in phagocytic activity, antibody production [111], delayed hypersensitivity [111, 112]) Increase in tumor inhibition and apoptotic rate (dose-related or time-dependent) [98\u2013103], similar effect at lower dose of 5-FU [105] Induce cell cycle arrest at different phases [99, 101], increase caspase 3 and 8 expression and activity [100]."}, {"generated": [], "gold": ["Clinical studies"], "text": "Clinical studies have reported on the benefits of Viscum album extracts (VAE) not only in breast cancer patients but also for other types of cancer [10\u201313]."}, {"generated": ["In vitro study"], "gold": ["in vitro"], "text": "Dextromethorphan in vitro inhibition profiles of CYP2D6 by reference inhibitor: Quinidine (0.1-1-2-5-10-100 \u03bcM)."}, {"generated": ["clinical"], "gold": ["clinical study"], "text": "Statistical analysis of results obtained from clinical study was performed using Student\u2019s paired t-test."}, {"generated": ["pharmacodynamic"], "gold": ["pharmacodynamic study"], "text": "Despite low levels of SITA, the combination demonstrated a significant reduction in blood glucose level when compared with individual drug and individual extract administered groups during pharmacodynamic study."}, {"generated": [], "gold": ["RCT"], "text": "Table 5  Cholesterol RCT interventions and effects of cholesterol RCT interventions on total cholesterol, HDL-C, LDL-C, and triglycerides."}, {"generated": [], "gold": ["RCT"], "text": "More specifically, most studies did not make clear the type of RCT being conducted and in many cases there were study design problems."}, {"generated": [], "gold": ["In vitro and in vivo studies"], "text": "Biological Mechanisms  In vitro and in vivo studies focused on mechanism of action have determined several potential mechanisms of the HS extracts that may explain the hypotensive activity, including (1) vasodilation mediated through endothelium-derived relaxant pathways and inhibition of calcium influx [9, 57], (2) ACE inhibition [9] by the stimulation of new vessel formation and a reduction of myocardial mass [52] or anthocyanins competing with the substrate for the active site [58], (3) decrease in blood viscosity through cyclooxygenase inhibitory activity [44], and (4) inhibition of adipocyte differentiation through the modulation of PI3-K/Akt and ERK pathway [59]."}, {"generated": [], "gold": ["modelling approaches combined with in vitro to in vivo extrapolation techniques"], "text": "Keywords: drug metabolism, herb\u2013drug interactions, modelling and simulation, physiologically\u2010based pharmacokinetic (PBPK) What is already known about this subject      Physiologically\u2010based pharmacokinetic (PBPK) modelling approaches combined with in vitro to in vivo extrapolation techniques have been extensively used for predicting clinically meaningful pharmacokinetic drug interactions."}, {"generated": ["extensive in vitro study"], "gold": ["in vitro study"], "text": "An extensive in vitro study showed that recombinant CYP2C8 enzyme (supersomes) was less sensitive than human liver microsomes (HLM) to identify potential mechanism\u2010based inhibitors and was characterised by a high lot\u2010to\u2010lot variability."}, {"generated": ["clinical trials"], "gold": ["trial designs"], "text": "PBPK simulations were also carried out to evaluate the capability of PBPK models of Schisandra lignans in predicting the extent of interactions with midazolam and tacrolimus with trial designs as detailed in Table 3."}, {"generated": ["Case reports"], "gold": ["case reports", "clinical reports"], "text": "Although there were no clinical reports in the literature pertaining to the interactions between Gegen and warfarin, the results of several case reports indicated that Danshen can interact with warfarin in humans [20\u201322]."}, {"generated": ["in vitro and in vivo study by Yueng"], "gold": ["in vitro and in vivo"], "text": "This finding is also supported by Yueng\u2019s study, where the major tanshinone components rather than the aqueous extract of Danshen showed effects on warfarin hydroxylation in vitro and in vivo [58]."}, {"generated": ["Research article"], "gold": ["in vivo effects"], "text": "In our study, although SAB was used as a major component of the Danshen granules, the in vivo effects were very different to those observed in cells because of the poor absorption and bioavailability of SAB."}, {"generated": ["In vitro and in vivo"], "gold": ["in vitro", "in vivo"], "text": "All of these factors could therefore be considered as potential explanations for the discrepancies observed between the in vitro and in vivo results."}, {"generated": ["In vitro and in vivo"], "gold": ["in vitro", "in vivo"], "text": "All of these factors could therefore be considered as potential explanations for the discrepancies observed between the in vitro and in vivo results."}, {"generated": [], "gold": ["In vitro"], "text": "Increasing use of medicinal herbs as nutritional supplements and traditional medicines for the treatment of diabetes, hypertension, hyperlipidemia, and malaria fever with conventional drugs poses possibilities of herb\u2013drug interactions ( In vitro inhibition of eight major   Mangifera indica moderately inhibited  Potential for clinically important     Funding information  This research did not receive any specific grant from funding agencies in the public, commercial, or not\u2010for\u2010profit sectors Management of chronic diseases is burdensome to patients (Eton et\u00a0al., 2013; \u00d8rtenblad, Meillier, & J\u00f8nsson, 2017) who tend to seek alternative remedies to conventional medications that may supposedly provide cure or offer safe use (Yarney et\u00a0al., 2013; Joeliantina, Agil, Qomaruddin, Jonosewojo, & Kusnanto, 2016) This self\u2010medication practice is common among chronically ill patients or patients with terminal diseases (Bodenheimer, Lorig, Holman, & Grumbach, 2002; Hasan, Ahmed, Bukhari, & Loon, 2009), and the major culprit in this group of patients are dietary supplements and herbal medicines (Gardiner, Graham, Legedza, Eisenberg, & Phillips, 2006; Gardiner, Phillips, & Shaughnessy, 2008)."}, {"generated": [], "gold": ["in vivo herb\u2013drug interaction studies", "In vitro herb\u2013drug interactions studies"], "text": "In vitro herb\u2013drug interactions studies are mostly conducted for commonly used herbs to evaluate and predict potentially significant in vivo herb\u2013drug interactions and to help design appropriate in vivo herb\u2013drug interaction studies (Fasinu, Bouic, & Rosenkranz, 2012; Awortwe, Bouic, Masimirembwa, & Rosenkranz, 2013)."}, {"generated": [], "gold": ["in vivo herb\u2013drug interaction studies", "In vitro herb\u2013drug interactions studies"], "text": "In vitro herb\u2013drug interactions studies are mostly conducted for commonly used herbs to evaluate and predict potentially significant in vivo herb\u2013drug interactions and to help design appropriate in vivo herb\u2013drug interaction studies (Fasinu, Bouic, & Rosenkranz, 2012; Awortwe, Bouic, Masimirembwa, & Rosenkranz, 2013)."}, {"generated": [], "gold": ["in vitro"], "text": "Gongronema latifolium and Alstonia boonei may produce in vivo inhibitory activity on CYP1A2, CYP2C19 and CYP3A4 since the converted in vitro IC One of the problems of studying herb\u2013drug interactions is the difficulty in identifying or quantifying the inhibiting components of the complex mixtures of phytochemicals in the herb."}, {"generated": [], "gold": ["Clinical studies"], "text": "Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John\u2019s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9]."}, {"generated": [], "gold": ["in-vitro screening", "ex-vivo", "in-vivo"], "text": "As shown in Table 1, after co-administration with RS, BIO of OS increased by 62% without change in its absorption rate (k  The developed pop-PK model lets us have an interpretation on the contradictory phenomena that co-administration of RS would increase both the elimination rate and systemic exposure (AUC The pop-PK model could separately estimate the metabolic clearance (CL  A platform including a six-dimension in-vitro screening, an in-vivo pharmacokinetics in rats and an ex-vivo pharmacodynamic evaluation, has been developed and successfully applied to find RS as a potential herb that would influence the co-administrated OS in rats."}, {"generated": [], "gold": ["in-vitro screening", "ex-vivo", "in-vivo"], "text": "As shown in Table 1, after co-administration with RS, BIO of OS increased by 62% without change in its absorption rate (k  The developed pop-PK model lets us have an interpretation on the contradictory phenomena that co-administration of RS would increase both the elimination rate and systemic exposure (AUC The pop-PK model could separately estimate the metabolic clearance (CL  A platform including a six-dimension in-vitro screening, an in-vivo pharmacokinetics in rats and an ex-vivo pharmacodynamic evaluation, has been developed and successfully applied to find RS as a potential herb that would influence the co-administrated OS in rats."}, {"generated": [], "gold": ["in-vitro screening", "ex-vivo", "in-vivo"], "text": "As shown in Table 1, after co-administration with RS, BIO of OS increased by 62% without change in its absorption rate (k  The developed pop-PK model lets us have an interpretation on the contradictory phenomena that co-administration of RS would increase both the elimination rate and systemic exposure (AUC The pop-PK model could separately estimate the metabolic clearance (CL  A platform including a six-dimension in-vitro screening, an in-vivo pharmacokinetics in rats and an ex-vivo pharmacodynamic evaluation, has been developed and successfully applied to find RS as a potential herb that would influence the co-administrated OS in rats."}, {"generated": [], "gold": ["Several controlled clinical studies"], "text": "Several controlled clinical studies, as shown by review and meta-analysis of published data, suggest that the use of ginkgo is associated with clinically significant improvement in symptoms of cognition decline and memory loss, anxiety and mood disorders, fatigue and general well-being, as well as cardiovascular disorders [59-61]."}, {"generated": [], "gold": ["human studies"], "text": "The inhibitory and inductive effect of the different phytochemicals in ginseng on CYP3A4 is demonstrated through the observed changes in the AUC and other pharmacokinetic parameters of midazolam in these human studies [27, 88]."}, {"generated": ["2-way, open-label crossover study"], "gold": ["open-label crossover study"], "text": "investigated the ability of SJW to interact with CYP3A4 in a 2-way, open-label crossover study of 21 healthy subjects using midazolam as the probe substrate."}, {"generated": [], "gold": ["vivo in several studies"], "text": "So, DEX has been used as a common probe for both CYP3A and CYP2D6 activities (Spanakis et al., 2009; Yu and Haining, 2001), as well as in vivo in several studies (Ducharme et al., 1996; Funck-Brentano et al., 2005; Jones et al., 1996)."}, {"generated": ["in vitro"], "gold": ["in vitro study"], "text": "In the in vitro study, Asafetida resin alcoholic extract inhibited the formation of DOR from DEX in a concentration dependent manner (Fig."}, {"generated": ["in vivo study"], "gold": ["vivo study"], "text": "The in vivo study was conducted on healthy human volunteers."}, {"generated": ["clinical"], "gold": ["clinical study"], "text": "Therefore, the clinical study was conducted to confirm the in vitro results."}]}